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CHARLES JOHN BEISCHEL. Studies on Photoaffmity Labeling and Mass 
Spectrometry of Bacteriorhodopsin. (Under the 
direction of ROSALIE K. CROUCH and DANIEL R. 
KNAPP.) 
The objective of these studies was to further defme the amino acids of 
bacteriorhodopsin in close proximity to the ring end of retinal by labeling them using a 
retinal analog modified to contain a photoactivatable group. The sites of labeling were 
to be identified using mass spectrometry and tandem mass spectrometry. 
Eight potentially photoactivatable retinal analogs were characterized and 
thoroughly examined as bacteriorhodopsin analog pigments thus identifying those 
analogs that were most similar to the native retinal. 
A versatile flash photolysis apparatus was compared to a continuous wave light 
source on the basis of total photon output and on efficiency of activation of a model 
photoactivatable compound. The flash apparatus activated the model compound four 
times more efficiently than the continuous wave source. The specially designed and 
constructed sample cell was efficient for photolysis studies. 
Molecular modeling of the retinal analogs and bacteriorhodopsin allowed enhanced 
visualization of the structures and predictions of potentially labeled amino acids. The 
hypothesis is that a photoactivatable retinal analog would label the amino acids predicted 
by these studies. The previously published reports of labeling of bacteriorhodopsin 
were evaluated suggesting that only one** of the retinal analogs was in the retinal 
binding site. 
Mass spectrometric analysis of cleavage fragments of bacteriorhodopsin identified 
49% of the protein. Nine percent of the protein was sequenced by tandem mass 
spectrometry. An unusual protein cleavage site was identified and confinned by tandem 
mass spectrometry. The identified peptides were the smallest of the predicted peptides 
from the cleavages. These initial studies indicated the utility of mass spectrometry in 
identification of labeled amino acids. 
Analysis of the three available tritiated, photoactivatable retinal analogs that fonned 
acceptable bacteriorhodopsin analog pigments by two different techniques showed no 
significant labeling of bacteriorhodopsin. Parallel positive control experiments 
estimated the limit of detection of labeling at <5%. 
Several modifications are suggested that should increase the likelihood of success 
for photo affinity labeling of bacteriorhodopsin with subsequent analysis by mass 
spectrometry. 
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The objective of this research was to defme which amino acids of bacteriorhodopsin 
(BR) are in close proximity to the ring portion of retinal. The methods used involve the 
design and synthesis of photoactivatable analogs of retinal, incorporation of the 
modified ligand into the apoprotein, characterization of the resulting analog pigments, 
photoactivation, and identification of labeled sites in the protein. A molecular model of 
BR was manipulated to predict the amino acids that are likely to be labeled by different 
retinal analogs and to evaluate already published labeling experiments. 
First, it is necessary to introduce the structure of BR, why it is relevant to 
pharmacology, how photoaffinity labeling experiments may further define its structure, 
and how mass spectrometry may be useful in identifying the labeled sites. Next, the 
subjects of photoactivation, molecular modeling, and identification of the amount of 
labeling using radio labeled photoactivatable reagent are briefly introouced. After this 
introduction, the objective, hypothesis and specific aims of this work are explicitly 
stated. The experimental investigation of the specific aims forms the body of the 
dissertation. Finally, in Chapter 7, the experimental results are summarized and 
suggestions are made for future work. 
Structure of Bacteriorhodopsin. The present understanding of BR has been gained 
through the exploitation of numerous biochemical and biophysical techniques. The 
more important aspects are briefly described here. BR is a 26 kilodalton integral 
membrane protein from the archaebacterium Halobacteriwn halobiwn. The protein 
functions as a light driven proton pump. The ecological niche for this bacterium is in 
environments of extremely high salt concentration (4 M in NaCI, 25% by weight, -25 
times that of seawater) such as the salt flats outside of San Francisco, CA and fish 
curing barrels [Stoeckenius et al., 1979]. In conditions that disfavor aerobic 
metabolism, such as low oxygen or lack of a reduced carbon source, BR provides the 
proton gradient necessary for the synthesis of ATP. The protein binds retinal (Vitamin A 
aldehyde, fig. 1.1) in a molar ratio of 1: 1. This association of the retinal with the 
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protein shifts the absorbance spectrum of the retinal from 380 nm (free in ethanol) to 
570 run (bound in BR) giving the protein its characteristic purple color. The purple 
color and the fact that when BR is isolated from the bacterium it exists in small patches 
of membrane have given it the name of purple membrane. There are three other 
homologous proteins in Halobacterium halobiwn, they are a light-driven chloride pump 
(halorhodopsin) and two phototactic pigments (sensory rhodopsin I and IT). These 
three proteins also bind retinal and are used by the bacterium to pump out excess 
chloride and to sense sources of useful light. Thus, these 'primitive' archaebacteria 
have developed a system that allows them to survive in very harsh conditions by 
harvesting sunlight when there is no food and no oxygen [Stoeckenius et al., 1979]. 
The primary structure of BR has been detennined by direct protein sequencing 
[Ovchinnikov et al., 1979; Khorana et al., 1979] and by DNA sequencing [Dunn et ai., 
1981]. A relatively low resolution (7 angstrom) three dimensional model ofBR which 
was based on electron diffraction data of a naturally occurring two dimensional crystal 
fonn of BR was published in 1975 [Henderson & Unwin, 1975]. This resolution gave 
infonnation on only the relatively large alpha helices, but the seven transmembrane 
helical (TMH) motif was unmistakable. Analysis of the sequence for areas that would 
likely fonn transmembrane helices yielded seven such sequences of between twenty and 
twenty-five amino acids (fig. 1.2). The connectivities of the seven transmembrane 
helices were proposed and were eventually shown to be correct [Engelman et al., 1980; 
Henderson et ai., 1990]. The retinal was shown to be linked by a protonated Schiff 
base to Lys216 [Bayley et al., 1981]. Neutron diffraction and linear dichroism studies 
have established the position of the retinal to be in the barrel made by the seven 
transmembrane helices and angled toward the cytoplasmic surface at about 20 degrees 
with the Schiff base linkage deep within the protein and the ring end closer to the 
cytoplasmic surface [Heyn et al., 1988] (see fig. 1.3). 
As reviewed by Khorana (1988), severa11abs have investigated the function ofBR 
and the tuning of the absorbance spectrum using mutants of the BR protein made with 
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molecular biological techniques. The mutants have been divided into three classes -
those that seem to have no effect on absorbance or proton pumping function, those that 
perturb the absorbance spectrum, and those that influence the proton pumping. These 
last two classes are not mutually exclusive. It is believed that those in the second group 
must line the retinal binding pocket to be able to influence the absorbance spectrum of 
retinal and that those in the third group are directly involved in the proton pumping 
mechanism. The amino acids placed in these sets by BR mutation experiments 
correspond well with the placement of the amino acids in the two different groups by 
Henderson et ale (1990) (see fig. 1.4 & 1.5). 
Upon the absorbance of a photon of light, BR photocycles through several 
spectrophotometrically discernible intermediate stages designated K through 0 which 
lead to proton pumping (fig. 1.6). The numbers associated with these different stages 
are the absorbance maxima of the intermediates in nanometers. Detailed spectroscopic 
studies have shown that the retinal cycles through changes in its conformation and 
protonation state. In the < 10 psec transition from the BR-570 state to the K-625 
intermediate the retinal undergoes an isomerization from all-trans to 13-cis, but remains 
protonated. During the -2 J.lsec transition from K-625 to L-550 the proton of the 
protonated Schiff base is believed to be being shifted to Asp85. Then after the - 40 
J.lsec transition to the M intermediate, the Schiff base is unprotonated and the protein is 
believed to be shifting protons up from the inside of the membrane to reprotonate the 
Schiff base. The decay from M-412 to 0-640 involves the reprotonation of the Schiff 
base and takes about 5 msec. This relatively slow decay makes it possible to take UV-
vis spectra of the M-intermediate at one msec after a flash of light that induces 
photocycling. In the transition from 0-640 back to BR-570 the retinal is reisomerized to 
the all-trans and the proton originally donated to Asp85 is shifted to the water on the 
outside of the membrane. This transition is also relatively slow and spectra taken at 5 
msec after an actinic flash capture the O-intermediate. During this photocycle the pKa's 
of several different amino acids' protonatable groups and the Schiff base change 
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sequentially to pass a proton vectorially from the inside of the membrane to the outside 
[Rothschild, 1992]. The conformation of the retinal in the binding site has been shown 
in the BR-570 state to be in the all-trans confonnation with the ring in the 6-s-trans 
confonnation. Thus, the conjugated double bond system is planar [Creuzet et al., 
1990]. 
A concise summary of these results related to the structure of BR is presented in the 
1990 paper of Henderson et al. which also presents electron diffraction data that are a 
landmark in the understanding of the structure of BR. This electron diffraction data is 
far superior to that reported in 1975. The resolution parallel to the membrane is 3.5 
angstroms and about 6 angstroms perpendicular to the plane of the membrane (Le. 
parallel to the long axis of the alpha helices). The diffraction data was collected at 4 K 
on tilted and non-tilted samples of partially dehydrated BR. The tilting of the samples 
allowed for more depth in the three dimensional view of the protein, albeit at relatively 
poor resolution. This resolution should be compared to that of X-ray diffraction of 
three dimensional crystals of proteins that can range to as low as 1-2 angstroms. 
Polypeptide chains can be delineated at 5-10 angstrom resolution. Groups of atoms can 
be distinguished at 2.8-4 angstrom resolution and individual atoms at around 2 
angstroms. When the individual atoms can be resolved this is called atomic resolution 
[Stryer, 1988]. The resolution acquired from the electron diffraction studies was 
sufficient for Henderson and his colleagues to build a three dimensional computer model 
of the structure of BR. The quality of the electron diffraction data allowed accurate 
modeling of the relatively bulky seven TMH and the relatively electron dense retinal. 
The extramembranous loops were not modeled since insufficient electron density was 
derived for these relatively free moving loops (fig. 1.3). Since the resolution is far from 
'atomic', there exists some ambiguity in the structure, especially in the arrangement of 
the less bulky sidechains of the amino acids in the alpha helices. This model contains 
178 of BR's 248 amino acids modeled as accurately as possible. It was subsequently 
deposited in the Brookhaven databank of protein structures. This structure of BR has 
become a working model for the protein that correlates well with the previous data 
[Henderson et al., 1990]. 
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Importance of BR Structure to Pharmacology. The details of the interaction between 
small molecules (ligands) and integral membrane receptor proteins are critical to the 
understanding of pharmacology at a molecular leveL Recently a large group of 
receptors for diverse ligands has been classed together by virtue of a common 
hydropathy profile that predicts the existence of seven trans-membrane helical regions. 
These receptors are influenced by the binding of a sma1lligand to a ligand binding 
domain that is believed to be inside the barrel fonned by the seven TMH. These ligands 
vary greatly to include, among others, the biogenic amines, retinals, endothelin and 
cannabinoids. Another reason these receptors are grouped together is that they bring 
about their intracellular response through the intennediary action of a GTP-binding 
regulatory protein. These receptors have thus been named the G-protein coupled 
receptors (OpeR) and more than seventy receptors have been included [Dohlman et al., 
1991; Probst et al., 1992]. The group includes (with their ligands in parentheses) the 
mammalian opsins (retinal), aI' a2 (norepinephrine), PI and P2 (epinephrine) -
adrenergic receptors, the muscarinic receptor family (acetylcholine), the 5lIT-lc and 5-
HT-la-receptors (serotonin), the substance K receptor, the endothelin receptor, Dl, D2, 
D3 receptors (dopamine), a cannabinol receptor and a functional angiotensin receptor 
[Probst et al., 1992 and references therein]. The prototype of this group is the visual 
pigment, rhodopsin. Substantial evidence exists for the correctness of this structural 
model for the rhodopsin molecule [Hargrave et al., 1983]. However, the strongest 
evidence for this structural motif comes from electron diffraction studies of 
bacteriorhodopsin (fig. 1.3). Thus, BR has become the structural prototype of this 
important class of receptors [Pardo etal., 1992; Hibert et ai., 1991]. BR shares with 
this group a similar hydropathy profile and more importantly the ability to bind and be 
influenced by a small 'ligand'. Thus, the interaction of retinal with BR has become a 
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powerful model for the interaction of the ligand with the binding domain of the GPCR. 
The utility of the BR structure as a starting point for modeling GPCR is evident 
from studies such as those of Hibert et ale (1991) in which the amino acids in the 
structure of BR are changed (in the computer) to the sequence of the protein under 
discussion. Hibert et al. concluded that such models 'enable structure-activity 
relationship studies and more rational drug design' on neurotransmitter GPeR. Pardo 
et ale (1992) advanced the use of the BR 'template' for modeling GPCR by suggesting 
that the linear sequence of the seven TMH need not be maintained, but that it is the 
geometric arrangement of the helices that should be followed. By taking the TMH as 
units, without regard to the linear sequence, they were able to show closer homology 
between BR and the GPeR. Pardo et ale suggest that the lack of sequence homology 
between BR and the GPCR is not surprising considering the large evolutionary distance 
between the archaebacteria and, for example, mammals. They suggest that the structural 
motif was conserved with the seven amphipathic TMH forming a binding pocket. 
It is important to note that the similarities between BR and GPCR are believed to be 
at the three dimensional structural level. Even BR and rhodopsin possess very little 
sequence homology. Also BR is not coupled to G-proteins. Even the phototactic 
pigments from Halobacteriwn halobium that must communicate with the inside of the 
cell to effect the swimming motion of the bacterium are not believed to be coupled to G-
proteins. Thus, BR is the structural prototype of the GPCR and rhodopsin is the best 
prototype, in general, of this pharmacologically important class of receptors. 
In addition to this importance as a structural prototype, BR is of considerable 
interest due to its ability to transduce light energy into a proton gradient. It converts 
photon energy into chemical potential energy. This process is at least triggered if not 
driven by the absorption of a photon by the bound retinal co-factor [Khorana, 1988]. 
Recent reports indicate the potential for BR in the development of a 'biochip' that could 
lead to a revolution in image detection [Hong, 1986; Miyasaka et al., 1992]. The image 
detector constructed by Miyasaka and his colleagues is tenned a biomolecular sensor 
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and is able to react within microseconds to changes in intensity while ignoring constant 
light - an attribute known as differential response. This type of response is difficult to 
mimic using 'silicon retinas' and is important in vivo for activities such as predators 
noticing the movement of prey [Flam, 1992]. 
The interaction of the 'ligand', retinal with the apo-protein, bacterioopsin is 
significant as a model for receptor-ligand interactions in general and as an energy-
transduction system. It is especially amenable to study at the molecular level because of 
its relative abundance, ease of manipulation and characterization, and the large amount 
of structural information available. 
Photoaffinity Labeling of BR. Photoaffmity labeling reagents are unreactive in the 
dark, but when activated by light, they become highly chemically reactive and are 
capable of fonning a covalent bond to a nearby molecule. Photoaffinity labeling 
reagents are normally designed to mimic the ligands of the protein of interest. By 
resembling the ligand of a receptor (or the substrate of an enzyme), photoaffmity 
labeling reagents can identify the protein in a mixture or identify a particular ligand 
binding site within a protein. The lack of reactivity in the dark allows the experimenter 
to perform basic tests on the biological activity of the ligand to show that it does bind to 
the native binding site. The reactive moiety of the photo affinity labeling reagent can be 
revealed at any point in the experiment by initiating the photolysis. This flexibility 
allows manipulations of the system in the dark that may enhance specific labeling of the 
ligand binding site. 
Several different types of photoactivatable groups are classed by the reactive 
intennediate produced when they are photolysed (fig. 1.7, top). One group shows the 
loss of molecular nitrogen to yield a carbene or nitrene. This group is thus subdivided 
into carbene precursors (e.g. diazo compounds and diazirines) and nitrene precursors 
(most often aryl azides). Another group works through radical mechanisms to label the 
nearby protein in a two step process. This group includes the a, ~-unsaturated ketone 
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compounds (fig. 1.7, top and bottom). The typical reactions of the extremely reactive 
carbenes and nitrenes are shown in fig. 1.7, middle. Nitrenes and carbenes react 
similarly, but carbenes are generally more reactive than nitrenes. The most useful 
reaction in this scheme is labeled insertion. The ability of the reactive intennediates to 
insert between C-H bonds shows just how reactive they are. This C-H insertion is the 
most stable bond that might be fonned. Other productive reactions (Le. those that will 
lead to stable bonds fonned with the protein) are addition to aromatic rings and reactions 
with nucleophiles. Dimerization reactions are not productive, but are unlikely to occur 
in the experiments described in this work since the retinal analog fonns a 1: 1 link with 
BR and is isolated deep inside the protein. The two step radical reactions of the a,J3-
unsaturated ketone groups are considerably less aggressive. In the BR system though, 
again due to the isolation and Schiff base link of the retinal analog in the binding pocket, 
the reactive group may be in contact with the protein long enough to stably label. These 
types of reactions have been successfully used to identify steroid receptors by 
photo affinity labeling [e.g. Hearne & Benisk, 1973]. 
With this introduction to photoactivatable groups and with the help of Bayley 
(1983), it is possible to rank the reactivities of the different photoactivatable groups as 
follows. Aryl azides have been surpassed by the electronegatively substituted nitro- and 
fluoro- arylazides for ability to undergo C-H insertion [Bayley, 1983; Keana & Cai, 
1988]. Carbenes are generally considered more reactive than nitrenes which makes 
diazo compounds and diazirines more desirable than azides. Diazirines are superior to 
diazo compounds since they can be activated at 365 nm [Huang et al., 1982; Nakayama 
& Khorana, 1990], well above the normal absorbance of the aromatic amino acids of the 
proteins. Thus, diazirines are superior to (» diazo compounds> electronegatively 
substituted aryl azides > aryl azides = unsaturated ketones> alkyl azides. 
An ideal photoaffinity labeling reagent should meet the following criteria [Bayley, 
1983]. 
• The reagent should be stable in the dark and in aqueous solution. 
• The reagent should be simple to synthesize and radiolabel. 
• The reagent should resemble the native ligand chemically so as to function 
similarly in the biological system. 
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• The photoactivatable group should be efficiently activated to a highly reactive 
intermediate at wavelengths and powers of light that do not damage the protein or the 
reagent itself. 
• The adducts formed must be stable to the analysis conditions. 
It would be extremely difficult to develop reagents that fit all of these criteria. As 
described in Chapter 2, several retinal analogs were designed and synthesized to. 
possess as many of these characteristics as possible. 
In designing photoactivatable retinal analogs, it is important to know from previous 
studies what types of chemical modifications of the retinal can be tolerated by the protein 
and still leave the BR analog pigment functional. Studies involving retinal analogs to 
investigate the retinal binding site have shown that the protein requires at least 4 
conjugated double bonds in the polyene side chain and only some parts of the ring in 
order to function. BR will tolerate bulky modifications to the ring end of the retinal, but 
only minor changes to the polyene side chain and Schiff base end of the chromophore 
[Crouch, 1986]. 
On the basis of experiments with selectively hydrogenated retinals, the 'external 
point charge' model was proposed to account for the nearly 200 nm opsin shift [Motto 
et al., 1980]. The 'external point charge' includes a counter-ion for the Schiff base and 
a negative charge near the ring portion of the retinal [Nakanishi et al., 1980]. These 
studies along with the previous photoaffinity labeling experiments with BR indicate that 
the most likely section of the retinal that can be modified (and retain function of the BR 
analog pigment) is the cyclohexenyl ring. 
The studies presented in this work were initiated prior to the publication of the 
landmark paper of Henderson et al., 1990 and at the time when only one report of 
photoaffinity labeling of BR had been published [Huang et al., 1982]. Since then two 
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reports of successful attempts to photoaffinity labeling of BR using photoactivatable 
retinal analogs have been published. BR is especially convenient for these studies since 
the retinal is covalently linked to the protein by the Schiff base at Lys216 which gives 
the equivalent of an extremely small Kd. Huang et ale (1982) showed specific labeling 
of Ser193 and Glu194 (fig. 1.8) using an aromatic analog of retinal (Khorana,,2., see 
fig. 1.1 for structure) as the photoactivatable retinal analog. They, however, did not 
demonstrate the ability of the analog pigment to pump protons or to form photocycle 
intermediates (i.e. biological activity) before or after cross-linking. Ding et ale (1990) 
published the second report of photoaffinity labeling of BR. With their analog 
(Nakanishil, l), they were able to demonstrate labeling of Thr121 and Gly122 (fig. 
1.8). The analog pigment formed from this photoactivatable retinal was shown to pump 
protons at about 1/3 the efficiency of native BR. The third report also came from 
Nakanishi's laboratory. Boehm et al. (1990) reported the labeling of amino acids 
Ala126, Leu127, Trp137 and Trp138 with another non-aromatic retinal analog that was 
a carbene precursor (4). They showed that the BR analog pigment fonned with this 
retinal analog functioned at about 1/3 the efficiency of native BR. Note that all of these 
retinal analogs contain photoactivatable groups that are carbene precursors. Also note 
that the labeling is spread over more than one amino acid in each site of labeling which 
may be due to actual labeling of these amino acids or inherent difficulties with the use of 
Edman degradation to identify labeled sites individually. Boehm et ale (1990) suggest 
that this spreading of the sites of labeling is due to an inherent weakness in the use of 
Edman degradation to identify the labeled sites. The photoactivatable retinal analogs 
used in the studies presented in this work were evaluated for their ability to form stable 
analog pigments, fonn photocycle intermediates, and pump protons. 
Mass Spectrometric Identification of Labeled Sites. As introduced above, the 
identification of labeled sites using Edman degradation of isolated peptides labeled with 
radioactively tagged retinal analogs is less than ideal. These methods require 
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purification to homogeneity of the labeled peptide for unambiguous Edman sequencing -
an often difficult task [Brinegar et al., 1988]. The elution of the radiolabel is often 
spread over more than one Edman cycle which makes identification of a single labeled 
site nearly impossible [Boehm et al., 1990]. This loss of resolution decreases the 
structural infonnation that can be obtained from the labeling experiment. For example, 
the identification of two sequential amino acids from an Edman sequencing run as 
labeled sites can change the interpretation by as much as a 100 degree rotation of an 
alpha helix. The conditions used for Edman sequencing (as well as other protein 
chemistry) may also remove or degrade the label [Dahlman et al., 1988; Kaur et al., 
1989]. 
The ability of mass spectrometry to analyze polypeptides has greatly increased in the 
last ten years due to the introduction of three different ionization techniques that can 
volatilize intact peptides. These techniques for mass spectrometry of peptides and 
proteins have been reviewed very recently [Biemann, 1992] and will be discussed only 
briefly here with particular attention to their possible use in photoaffinity labeling 
experiments of BR. The first of these techniques was introduced by Barber et ale 
(1981) and is called fast atom bombardment (FAB) ionization. In this technique, a 
peptide or mixture of peptides is ionized from a liquid matrix (often glycerol) by a beam 
of high energy atoms or ions. Peptides undergo very little degradation in this ionization 
process and the protonated molecular ion (M+H)+ is usually the most intense. Most 
peptides are amenable to fast atom bombardment MS. However, some very 
hydrophylic and very hydrophobic peptides are more difficult to analyze with standard 
FAB techniques. In general the sensitivity of fast atom bombardment MS decreases 
with increasing mass. At approximately six thousand daltons the sensitivity has 
decreased to a point that the other ionization techniques are often more useful. The 
accurate measurement of the mass of a peptide can answer many questions about its 
structure including the correctness of an amino acid sequence derived from DNA 
sequence, the detection of natural or biosynthetic mutations, and of most interest here 
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the identification of chemical modifications including photoaffinity labels. The use of 
MS in detection and identification of photoaffmity labeling will be further discussed 
below. 
The other two ionization techniques have greatly expanded the mass range for 
analysis of peptides and large proteins with hemoglobins (-15 000 mol. wt.), albumins 
(-60 000 mol. wt.) and monoclonal antibodies (-150 000 mol. wt.) often being 
reported. Electrospray ionization extends the nominal mass range of the instrument by 
generating mUltiply charged ions. The ionization process involves the fonnation of tiny, 
usually acidic, droplets containing the sample peptide. These droplets are de solvated in 
in a heated capillary interfaced to the vacuum of the mass spectrometer and the sample is 
eventually left multiply charged and free of solvent. The other ionization technique is 
matrix assisted laser desorption. In this technique, the sample is crystallized with a light 
absorbing matrix. The sample/matrix mixture is then irradiated and the sample is 
ionized. It has recently been shown that mass measurements on BR and bleached BR 
(bacterioopsin) can be obtained using matrix assisted laser desorption (MALD)- time of 
flight mass spectrometry [Schey et al., 1992]. MALD - time of flight mass 
spectrometry can distinguish these two samples, when they are run individually, that 
differ only by the mass of the retinal. However, these techniques could not resolve the 
two species in a sample that contained both [Schey et al., 1992]. This method, 
therefore, would not be able to resolve an unlabeled BR molecule from a fraction that 
was mass shifted by -300 daltons by the addition of a photoactivatable retinal analog as 
part of the same sample. It could be extremely useful in other aspects of identification 
of labeled peptides after cleavage of BR. For example the entire reaction mixture from a 
chemical or enzymatic cleavage could be analyzed to assure complete reaction and to 
look for mass shifted peptides. Since these two ionization techniques were only very 
recently introduced to the laboratory, they were not used in the work described here. 
Since these ionization techniques result in the molecular ion and not much 
fragmentation, structural infonnation on the individual peptides is lacking and must be 
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derived after further fragmentation. This fragmentation is achieved in tandem mass 
spectrometry by selecting a peptide with the frrst mass spectrometer and then colliding 
the peptide with helium. This collision imparts excess internal energy to the peptide and 
the peptide fragments. This process is termed collision induced dissociation. The 
second mass spectrometer is then used to analyze the resulting fragments. All of these 
product ions come from the single peptide chosen by the fITst mass spectrometer.. These 
ions, thus, contain information only about the selected peptide. Fortunately, peptides 
consist of a linear sequence of only 20 different amino acids. With two exceptions (Leu 
and lie; Lys and GIn) the amino acids have unique masses (fig. 1.9). Interpretation of 
fragmentations is aided by the fact that peptides tend to fragment between the individual 
amino acid residues in only a few different ways (fig. 1.9). This leads to only a limited 
number of types of sequence ions. A common nomenclature has been adopted for these 
ions (fig. 1.9). The ions named from the end of the alphabet result from charge 
retention on the C-tenninal end of the peptide and those named from the beginning of 
the alphabet have charge retention by the N-tenninal of the peptide. Ions derived from a 
single series allow sequence information of the peptide to be derived from the mass 
differences between the peaks. For example, two y series ions that differ by mass 57 
indicate a glycine at that position. Multiple series are often present allowing overlapping 
information to further verify the structure. With practice, and especially with known 
cleavage specificities, the sequence of a peptide can be completely derived from its 
tandem mass spectrum. Under favorable conditions, complete unknowns can be 
sequenced [e.g. Schluter et ai., 1990]. Peptides for which sequence information is 
available make the assignments particularly straightforward since the fragment ions can 
be predicted from the structure (especially simply with the aid of computer applications 
such as MacProMass [Lee & Verumi, 1990]). Because the sequence information is 
dependent only on the mass of the residues, chemical modifications can often be 
sequence specifically identified [Biemann and ScobIe, 1987; Papac et al., 1992]. 
The method of identifying sites of labeling sequence specifically with MS/MS is 
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complex. Presented in fig. 1.10 is a diagrammatic representation of the analysis of one 
HPLC fraction that contains several peptides (PI, P2, P3) including one that is mass 
shifted because it is labeled (P2*). The boxes along the top are the different stages in 
the mass spectrometer. The three spectra shown are the MS spectrum of the peptide 
mixture (left) and the MS/MS spectra of the non-labeled and labeled peptide P2 (right). 
The MS spectrum (left) shows that the peptide is shifted by the mass of the label (M*). 
In the MS/MS spectrum of the labeled peptide (P2*) each peptide fragment that contains 
the label (e.g. ABC*) is mass shifted from the corresponding peptide (e.g. ABC) in the 
non-labeled MS/MS spectrum of P2 by the mass of the label (*). It is possible, 
although unlikely, that labeled and non-labeled versions of the same peptide would co-
elute on HPLC. They are shown here together to simplify the comparison. It is also 
possible that the relative amounts of the labeled and non-labeled peptide could vary 
widely depending upon the efficiency of incorporation of the label. The depiction 
described in this figure has the label bound to amino acid C of the labeled peptide P2 * 
whose sequence is ABeD. 
There are two different requirements for identifying the sites of labeling in a 
photoaffinity labeling experiment. The labeled peptide must first be detected. Then, the 
site of labeling within this peptide must be identified. The use of mass spectrometry to 
identify sites of photoaffinity labeling has been reported [Brinegar et al., 1988; Chen et 
al., 1986]. Chen et ale used concomitant sequencing by Edman methcx:ls and fast atom 
bombardment MS to identify a site of labeling. The labeled peptide was purified 
chromatographically and detected by the presence of radiolabel on the photoaffinity 
reagent. The site of labeling was identified by Edman sequencing and a single mass 
spectrum confirmed the mass shift of the peptide by the mass of the label. Note that 
mass spectrometry was not used to identify the site of labeling nor to detect the labeled 
peptide, but simply confirmed their results. The work presented by Brinegar et ale 
(1988) again describes the use of MS to confmn a site of labeling already detennined by 
the more classical methods of radiolabeling and Edman sequencing. They, however, do 
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confmn the sequence specific site of labeling using MS/MS with a spectrum very much 
like that for P2* in fig. 1.10. Note that these studies use MS and MS/MS to identify 
sites of labeling on a peptide already known to be labeled. 
Previously, mass spectrometry has been used to map the peptides derived from 
CNBr cleavage of BR [Allmaier et al., 1986]. Working in Biemann's lab at the 
Massachusetts Institute of Technology, they were able to detect nine of the ten peptides 
predicted from this cleavage including the highest mass peptide at -5400 daltons. These 
results indicate the potential utility of this high mass fast atom bombardment MS to 
detect mass shifts in these peptides resulting from photoaffinity labeling. It should be 
emphasized that the application of these techniques to large and hydrophobic peptides is 
complex. The added difficulty that only a fraction of a particular peptide would be mass 
shifted by attachment of the photoaffmity label made the detection of labeled peptides 
and identification of labeled sites by MS a major undertaking. 
The recent addition to MUSC of state of the art facilities for these techniques 
including a JEOL HX110/HX110 high mass, high performance tandem mass 
spectrometer encouraged the use of sophisticated applications of MS and MS/MS to the 
study of photoaffinity labeling of BR. The studies on peptides from BR presented in 
Chapter 6 represent the initial use of the JEOL HX110/HX110 mass spectrometer at 
MUSC. These studies were initiated late in the overall sequence of the work presented 
here and represent initial studies using MS in anticipation of labeled protein being 
derived from the rest of the studies. Also in Appendix 2, presented as an example of the 
power of these mass spectrometric studies, is a summary of the mass spectrometric 
analysis of shark immunoglobulin light chains performed with Stephen Martin in Klaus 
Biemann's laboratory at the Massachusetts Institute of Technology in collaboration with 
Sam Schluter and Jack Marchalonis. 
P hotoactivation. The ability to activate the photoactivatable groups of the retinal 
analogs without damage to the protein is a requirement for these types of experiments. 
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To this end, two different light sources were evaluated. The Rayonet Photochemical 
Reactor-100 (RPR) equipped with nomina1350 nm wavelength bulbs was used as a 
source of continuous wave light. A flash photolysis apparatus with a xenon flashlamp 
delivering broadband radiation (-200-500 nm) in approximately microsecond pulses 
was also employed. These two light sources are compared for emission spectra, total 
photon output as measured by chemical actinometry, protein damaging effects (as 
shown by SDS-PAGE and absorbance changes of BR), and efficiency of activation of a 
model compound. Both sources use a specially constructed sample cell that allows 
efficient exposure of the sample. These studies are fully described in Chapter 3. 
Molecular Modeling used to Predict Sites of Labeling. In order to predict and 
evaluate photoaffinity labeled sites on BR with different retinal analogs, Henderson's 
model [Henderson et al., 1990] was manipulated using the molecular modeling package 
SYBYL (TRIPOS Inc., St Louis, MO) running on the MUSe Vax 11n85 computer 
(e.g. fig. 1.3). These tools allowed easy manipulation and investigation of the 
structure. The sets of amino acids that are predicted to be the correct distance from the 
retinal analog's photoactivatable moiety to be potentially labeled in these experiments 
served as hypotheses for the photoaffinity labeling experiments. It is hypothesized that 
a photoactivatable retinal analog bound in the native retinal binding site will label amino 
acids that were predicted to be properly situated in the three dimensional structure of the 
protein to be contacted by the reactive intermediate. These predictions were also carried 
out for the three already published photoaffinity labeling experiments of BR. These 
studies are described in detail in Chapter 4. 
Identification of Amount of Labeling Using Radiolabeled Photoactivatable Reagent. 
As was suggested earlier, attempting to detect and identify sites of labeling of BR by 
mass spectrometry alone was an ambitious undertaking. The use of radiolabeled, 
photoactivatable retinal analogs and more classical biochemical techniques for detecting 
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amount of labeling and identifying labeled peptides was suggested early in this work. 
The techniques used to evaluate the ability of the two available radiolabeled retinal 
analogs, that formed acceptable BR analog pigments, to crosslink to BR in a photolysis 
dependent manner are not novel [Huang et ai., 1982; Ding et aI., 1990]. The analysis 
of TF4N3 was incorporated late in these studies due to the difficulty in obtaining 
radiolabeled TF4N3. The studies using the more classical techniques for evaluation of 
labeling with TF4N3 are described in detail in Chapter 5. 
With this introduction, the following explicit statement of the objective, hypothesis 
and specific aims of this dissertation should be clear. 
Objective: Define the amino acids of BR that are in close proximity to the ring of the 
retinal using photoactivatable retinal analogs and mass spectrometric identification of 
labeled sites. 
Hypothesis: Identification of photoaffinity labeled sites in BR will aid in further 
definition of ligand/receptor interactions of the receptors belonging to the GPCR class. 
Specific Aims: 
1) Determine the stability and functional characteristics of BR analog pigments 
formed with photoactivatable retinal analogs in order to evaluate their usefulness in 
photoaffinity labeling experiments. 
2) Define appropriate light sources and photolysis conditions for the 
photoactivatable moieties of the retinal analogs that form acceptable BR analog 
pigments. 
3) Predict and evaluate photoaffinity labeled sites of BR using molecular modeling. 
4) Determine if and to what extent photoactivatable retinal analogs label BR using 
radiolabeled versions of the retinal analogs. 
5) Evaluate the use of mass spectrometry and tandem mass spectrometry to define 










Figure 1.1 All-trans Retinal & Previously Published 
Photoactivatable Retinal Analogs 
1: The chemical structure of all-trans retinal, the native 
chromophore of bacteriorhodopsin. The conventional numbering system of the 
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Figure 1.2 Bacteriorhodopsin, T\vo Dimensional Model 
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Two dirnensional depiction of the structure of bacteriorhodopsin. The seven 
transmembrane helices are boxed and lettered A-G . Lysine 216 to which the retinal 
is bonded by a Schiff base is circled. For single letter amino acid codes, see list of 
abbreviations. Adapted from Henderson el aI., 1990. 
Figure 1.3 Bacteriorhodopsin, Molecular Model, Ribbon 
Depictions of the three dimensional structure of bacteriorhodop in 
with ribbons threaded through the a carbons of the seven 
transmen1brane helices. Lysin 216 and retinal are shown in gray 
and as a ball & stick model in the botton1 panel. 
Adapted with SYBYL fron1 H nderson et al., 1990. 
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Figure 1.4 Bacteriorhodopsin, Proton Channel 
Two dimensional depiction of the structure of bacteriorhodopsin. The seven 
transmembrane helices are boxed and lettered A -G . Lysine 216 to which the 
retinal is bonded by a Schiff base is circled. The other an1ino acids in the 
proton channel are also circled. Adapted from Henderson et al., 1990. 
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Figure 1.5 Bacteriorhodopsin, Retinal Binding Pocket 
Two dimensional depiction of the stnlcture of bacreriorhodopsin. The seven 
transnlembrane helices are boxed and lettered A-G . Lysine 216 to which the 
retinal is bonded by a Schiff base is circled. Amino acids in the retinal 
binding pocket are in squares . Adapted from Henderson et al., 1990. 
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H+ N - 560 
1\1 - 412 
Figure 1.6 Bacteriorhodopsin Photocycie 
/ 
~ 
K - 610 
L - 550 
A scheme for the photochemical cycle of BR. The cycle is initiated by light absorption 
by BR - 570. A proton is released on the outside and another taken up from the inside 
at the steps indicated. The nun1bcrs indicatc thc absorbance n1axinlun1 of the 
intermediate in nanometers. Adaptcd fron1 Henderson et aL., 1990. 
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Figure 1.7 Common Photoactivatable (;roups and 
Typical Chemical Reactions of Photoactiv3 ted. Intt:i 'rnediates 
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Middle scheme shows re~c.ti.o.n5. of c ::ro~ .r;,t:;y 'and nitrenes. Bottonl scheme shows 
mechanism of reaction of photoactivatible keto compounds. 
Adapted from Bayley, 1983 . 
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Two dimensional depiction of the structure of bacteriorhodopsin. The seven 
transmembrane helices are boxed and lettered A-G. Lysine 216 to which the retinal 
is bonded by a Schiff base is circled. Ser193 and Glu194 were labeled by 2 and 
are boxed [Huang et al., 1982]. Thr121 and Gly122 were labeled by J. and are 
in diamonds [Ding et al., 1990]. Ala126, Leu127, Trp137 and Trp138 were labeled 
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Figure 1.8 Previously Labeled Sites 
Two dimensional depiction of the structure of bacteriorhodopsin. The seven 
transmembrane helices are boxed and lettered A-G. Lysine 216 to which the retinal 
is bonded by a Schiff base is circled. Ser193 and Glu194 were labeled by Z and 
are boxed [Huang et al., 1982]. Thr121 and Gly122 were labeled by J and are 
in diamonds [Ding et al., 1990]. Ala126, Leu127, Trp137 and Trp138 were labeled 
by ~ and are in thick circles [Boehm et aI., 1990]. 
Fragnlent Ions Produced by CID fronl Protonated Peptides 
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Figure 1.9 CID Nomenclature and Mass of Anlino Acid Residues 
Adapted fronl Bienlann, 1992. 
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PEPTIDES ANALYZED BY MS AND MS/MS TO DETERMINE 
SPECIFIC SITE(S) OF LABELING 
HPLC FRACTION 
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Diagram of MS and MS/MS identification of labeled peptides. Each fraction from HPL 1 
analyzed by MS to dctcnnine the presencc of pcplides predicted from the known sequence and 
the cleavage mcthod . The scquence of these peptides can be confirnlcd by MS/MS eP2). 
Unexpected peptidcs can be analyzed by MS/MS to show that they are the result of an unusual 
cleavage (not depictcd) or that they have becn mass shiftcd as the result of labeling (P2*). 
The MS/MS speCLrUnl can show the site of labeling sequence specifically. 
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Chapter 2 
Retinal Analogs and BR Analog Pigments 
Portions of this chapter have been published as 
Beischel, CJ, V Mani, R Govindjee, TG Ebrey, DR Knapp, and RK Crouch. 
"Ring Oxidized Retinals Ponn Unusual Bacteriorhodopsin Analog Pigments." 
Photochem. PhotobioL 54(6), 977-983, 1991 
and 
Beischel, CJ, V Mani, EA Cohen, DR Knapp, and RK Crouch. 
"A Novel Photo affinity Label for Bacteriorhodopsin." 
Biophys. J. 57(2), 365a, 1990. 
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Introduction. 
The use of retinals that have been modified chemically to possess a specific 
probe of the retinal binding site of BR has a long history in this laboratory and in others. 
More than fifty different retinal analogs have been tested for interaction with the protein 
[Crouch, 1986]. In this project, retinal derivatives that contain a photoactivatable 
moiety were desired. When incorporated into the protein and properly activated, these 
analogs should covalently link to the amino acids close to them. These retinal analogs 
must be designed to come as close as possible to the following characteristics of an ideal 
photoaffinity label for BR [adapted from Bayley, 1983]. 
• Easy to synthesize and radiolabel. 
• Forms stable, functional BR analog pigment (Le. biological activity) 
• Stable in the dark and in aqueous solution. 
• Able to be photoactivated to a highly reactive intermediate that forms a stable 
covalent crosslink with the protein by a wavelength and amount of light that 
does not damage the protein. 
Compounds ~ -U were designed and synthesized with these criteria in mind. They 
were then evaluated for stable pigment formation and proton pumping function (i.e. 
biological activity). The chemical modifications were made to these compounds to make 
them potentially photoactivatable while remaining within the constraints derived from 
knowledge of other retinal analogs that have successfully fanned stable, functional 
analog pigments [Crouch, 1986]. The compounds 13-15 were synthesized as 
intermediates in the synthetic schemes of the other retinal analogs and pigments were 
formed with these compounds since they are novel analogs. They are included here for 
completeness. 
The analogs that are a.-~ unsaturated ketones were synthesized based on the 
precedent of using a-~ unsaturated keto steroids to photolabel their receptors [Hearne & 
Benisk, 1973; Gronemeyer, 1985]. Compound 1 was isolated as an unexpected 
product of the oxidation of retinal by Mn02. Compounds ~,~,and I were synthesized 
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and purified by Dr. Venkat Mani. Compound B. is based on the use of the classic aryl 
azide as a photoactivatable group. This compound was synthesized in limited quantities 
by Dr. Valeria Balogh-Nair at the City College of New York. The small quantity limited 
the analysis to pigment formation. This compound was also not radiolabeled. 
Compound 2" also synthesized by Dr. Balogh-Nair, showed great promise since it has 
the highly reactive diazirine photoactivatable group and was supplied in sufficient 
quantity for many studies. However, it was not radiolabeled. Compound JJl was 
synthesized by Dr. Venkat Mani from compound 14, a gift from Hoffman-LaRoche and 
2-diazo-3,3,3-trifluoropropionyl chloride, commercially available from Pierce Chemical 
Co. It contained a carbene precursor, but did not form a stable pigment. Compound 
li, tetrafluoro-4-azidoretinal (TF4N3) was very difficult to synthesize and characterize. 
An outline of the synthetic scheme is included in appendix 1. This compound was 
originally synthesized by Dr. Venkat Mani; more recently Dr. Bernice Katz has further 
developed the synthesis. The model studies described in Chapter 3 are based on this 
potentially very useful photoactivatable group [Leyva et al., 1986a, b; Keana and Cai, 
1988]. This retinal analog was fully characterized as the BR analog pigment as 
described below. It was eventually available in tritiated form. Compound 12, an 
acyclic photoactivatable retinal, was recently synthesized by Dr. John Oatis in small 
quantities and will soon be prepared in radiolabeled form for further evaluation. 
Compounds l.,l and 4, used in the previously published photoaffinity labeling 
experiments ofBR [Huang eta!., 1982; Ding etal., 1990], are shown in fig. 1.1 for 
comparison. The compounds U-ll are synthetic intermediates and were analyzed to 
predict whether the final product would likely fonn pigment and in the case of lJ, 
pentafluororetinal, the pigment characteristics allowed discrimination of this compound 
and the final product of the synthesis 11. Compound 13 was synthesized and 
characterized similarly to II and is described in the appendix. Compound 14 was a gift 
from Hoffman-LaRoche to Dr. Venkat Mani. He synthesized from this compound, 
compounds II and lll. These compounds were characterized by Dr. Mani for use in 
these experiments. 
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Materials and Methods. 
The methods used to evaluate the analogs as pigments are well established and 
described below [Crouch, 1986, Beischel etal., 1991, Govindjee eta/., 1980]. 
All UV-visible spectra were recorded at room temperature using semi-micro masked 
cuvettes (1 ml, Markson) on a Varian Cary 2200 spectrophotometer interfaced to an 
IBM XT through a program in ASYST (Macmillan Software) written by DW Corson 
and J Reider. Incorporation of interactive graphics into the program to visually confinn 
the goodness of fit of the absorbance maximum detennining routine were added as part 
of this work. Spectra were routinely recorded from 700 to 250 nm at room temperature. 
Unless otherwise noted, retinal analogs were dissolved in ethanol and BR analog 
pigments in water. 
The infrared absorbance spectra of the retinal analogs were recorded on a Mattson 
Polaris Fourier Transfonn Infrared Spectrophotometer and analyzed with the dedicated 
ICON software. Samples of the retinals in deuterated chloroform were analyzed in a 
NaCI sample cell (O.I-mm path length). The sample compartment was purged with 
nitrogen and the spectra were recorded from 4000 to 800 cm -1 at 1.0 cm -1 resolution. 
Gas chromatography-mass spectrometry (GC-MS) analyses of retinal analogs and 
other compounds were made on a Hewlett-Packard MSD 5970B GC-MS instrument 
using a fused silica capillary column containing methylsilicone as the stationary phase 
with He as carrier gas. Approximately 1 Jlg of the compound to be analyzed was 
injected in an ethanol solution and the temperature ramped from 50°C to 290°C in 15 
minutes while repetitively scanning from 50-400 rn/z. 
High performance liquid chromatography (HPLC) of the retinal analogs was 
performed using a Varian 5000 HPLC pump and an Alltech 5Jlm Econosphere silica 
column with detection using a Waters 994 Photodiode array detector. Absorbance data 
were recorded from 200 - 500 nm. Solvent gradients were from 100% hexanes to 
75:25 hexanes:90/10 ethyl acetate/methanol in 25 minutes. 
Protonated Schiff bases of the retinal analogs were prepared by the addition of n-
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butylamine (20J..lI, 0.5M, Sigma) in dry hexanes (Curtin Matheson) to the respective 
retinal in dry ethanol (-0.1 Jlg/ml) and allowing 15 minutes for the formation of the 
Schiff base which was monitored spectrally. The ethanolic solution was then acidified 
with trifluoroacetic acid (1 Jl.l/ml, Pierce) and the absorbance spectrum recorded. 
Bacteriorhodopsin and analog pigments. Purple membrane was purified from 
cultures of Halobacteriwn halobiwn grown in synthetic basal salt media [Gochnauer and 
Kushner, 1969] by the method of Becher and Cassim (1975) with an additional sucrose 
gradient purification (30-60% sucrose, 100,000 g, 17 h). Bleached membrane was 
prepared by a modification of the method of Tokunaga et ale (1977). Purple membrane 
was bleached by exposure to bright white light at 37°C in a solution of 1 M NH20H, 
0.1 M NaCl and 10 mM Tris buffer (pH 9.5) for -4 h. Retinyloximes were removed by 
hexane washes. The analog pigments were fonned by the incremental addition of a 
concentrated ethanolic solution of the retinal analogs to bleached membrane in distilled 
water with stirring and the absorbance spectra were recorded using bleached purple 
membrane as the reference. The retinal analog was added until no further change in the 
absorbance maximum of the analog pigment occurred. The [mal concentration of 
ethanol was <1 %. Stability of the pigment to hydroxylamine was measured by the 
addition of 20 ml of 1 M NH20H (pH 7) to the pigment and observation of the 
absorbance over several hours. Possible displacement of the retinal analog by all-trans 
retinal was detennined by addition of a three-fold molar excess of all-trans retinal to the 
analog pigment. Absorbance was monitored over several hours with specific attention 
to an increased absorbance at 558 nm, the maximum of the native retinal based pigment. 
Samples were irradiated with a fiber optics directed microscope illuminator 
(Dyonics, 150 W). Reversible light adaptation was accomplished by a 2 min exposure 
of the pigments to white light (100 mW/cm2) from the same source. Dark adaptation 
was monitored until no further shift in the absorbance maximum occurred. 
Extraction of retinals. Pigments fonned with tritiated retinals (-1 mg) were pelleted 
(100 000 g, 20 min) and the supernatant decanted and counted as below. The pigment 
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was solubilized with 1 M NH20H (100 ~l), 10% SDS (25 ).11), and sodium phosphate 
buffer (50 mM, pH 9.5, 175 Ill). Methanol (300 J.11) was added to the mixture which 
was then vortexed and heated at 400 C (10 min). The retinals were extracted 2X with 
500 III of dichloromethane. Samples were counted in Aquasol-2 (5 ml, DuPont). 
Photocycle intermediates and proton pumping. (These experiments were perfonned 
by Dr. Rajni Govindjee and Dr. Tom Ebrey at the University of Illinois - Urbana-
Champaign, Department of Biophysics according to Govindjee et al., 1980.) Flash-
induced absorbance changes of the pigments were measured with a kinetic spectrometer 
in 100 mM KCI pH 7.0. The actinic flash was from a Nd-YAG laser (532 nm, 7 ns: 
Quanta Ray DCR 11). Proton release and uptake were observed by measuring the 
absorbance changes of the pH sensitive dye, pyranine. The light-induced difference 
spectra were measured with an optical multichannel analyzer system (Princeton 
Instruments Corp., Princeton, NJ). Each difference spectrum is an average of 16 
flashes. 
The number, trivial and systematic names of the retinal analogs that were 
synthesized for these studies are presented for completeness and ease of future 
reference. 
s., 4-oxoretinal, [9-(3' -oxo-2' ,6' ,6' -trimethyl-1' -cyclohexenyl)-3,7-dimethyl-2,4,6,8-
nonatetraenal] . 
6., 2,3 dehydro 4-oxoretinal, [9-(3' -oxo-2' ,6' ,6' -trimethyl-1' ,4' -cyclohexadienyl)-3,7-
dimethyl-2,4,6,8-nonatetraenal] . 
1, Dioxocyclopentenylretinal, [9-(3' ,4' -dioxo-2' ,5' ,5' -trimethyl-1' -cyclopentenyl)-3,7-
dimethyl-2,4,6,8-nonatetraenal]. 
R" VBN-I, [9-(4-azido-2,6-dimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenal]. 




11, TF4N3, [9-( 4-azido-2,3,5,6-tetrafluorophenyl)-3,7 -dimethy 1-2,4,6,8-
nonatetraenal] 
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11, Acyclicretinal, [5' ,9' -dimethyl-2' -isopropyl-11-oxo-3' ,5' ,7' ,9' -undecatetraenyl-2-
diazo-3,3,3-trifluoropropanoate]. 





non ate traen al] . 
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Results. 
4-0xoretinals (~,6,7). 4-0xoretina11, 2,3 dehydro-4-oxoretinal ~, and 
dioxocyclo-pentenylretinal 7 are fonned from the prolonged exposure of all-trans retinal 
1 to activated manganese dioxide. Only the all-trans isomers were isolated. The UV-
vis, infrared, mass and NMR spectra of these three oxoretinals [Williams and Mani, 
1991] confinn the structures as depicted in fig. 2.1. Compounds ~ , .6. and 2 show an 
intense absorbance in their infrared spectra consistent with the presence of carbonyl 
function(s) other than the conjugated aldehyde as detennined by comparison with the 
infrared spectrum of all-trans retinall. Compound 1 has another carbonyl peak in its 
infrared spectrum corresponding to the second ring carbonyl. They each display an 
absorbance maximum greater than 350 nm consistent with their extended conjugation. 
However, the cyclopentenyl derivative 7 has a Amax significantly red shifted from the 
Amax of most retinals (435 nm vs. 380 nm, fig. 2.2). The absorbance data for the 
retinals and the corresponding protonated Schiff bases are shown in figure 2.10. 
Interestingly, whereas the Amax of the unprotonated Schiff base of 1 remains strongly 
red shifted by 81 nm from that of retinall, the Amax of the protonated Schiff base of 7 
(455 nm) is close to that for retinal itself (444 nm). 
All three oxoretinals form stable analog pigments with bacterioopsin (fig. 2.2). The 
properties of these pigments and those of regenerated BR are summarized in figure 
2.10. The absorbance maxima for these three pigments are all similar in spite of the 
differences in the absorbance of the retinals. The cyclopentenyl retinal 7 has a smaller 
"opsin shift" (Motto et aI., 1980) than the other oxopigments (2 600 vs. 4 400 cm- 1). 
The rate of formation of pigment from dioxocyclopenteny lretinal 1 is comparable to that 
of all-trans retinal whereas pigment formation with the other two oxoretinals s.. and.6. is 
considerably slower (t1\2 of 5 min as compared with t1\2 of <1 min). The oxoretinal 
analog pigments have absorbance maxima blue shifted about 50 nrn from that of native 
BR. The pigments fonned are all reasonably stable to the addition of hydroxylamine, as 
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no significant loss of pigment was observed after 60 min in the presence of 20 mM 
hydroxylamine. Likewise, addition of all-trans retinal to the oxoretinal analog pigments 
did not result in a decrease in absorbance at the pigments' maxima or an increase in 
absorbance at 558 nm, the maximum of dark-adapted BR. 
Exposure of the three oxoretinal pigments to the white light source which reversibly 
light adapts (2 min, 10 nm red shift) native BR resulted in an irreversible -20 nm blue 
shift in their respective absorbance maxima which was complete after 15 min irradiation. 
After 1 h in the dark, the previously illuminated pigments of ~ and i showed 4-8 nm 
red shifts which were reversible upon 2 min illumination (fig. 2.2, bottom panel). 
However, incubation of the illuminated oxoretinall pigment in the dark for up to two 
weeks did not result in any change in its Amax (fig. 2.3). 
The flash-induced difference spectra of the illuminated and non-illuminated s.. and ~ 
based pigments show a decrease in absorbance near the absorbance maximum of the 
pigment and an increase near 370-410 nm (fig. 2.4, 2.5). The flash induced difference 
spectra in the millisecond time scale of illuminated and non-illuminated pigment S. (fig. 
2.6) are somewhat different. The non-illuminated fonn (fig. 2.6, top) shows a decrease 
in absorbance at 470 nm, an 'M' -like intermediate at -370 nm, and a small increase in 
absorbance at 550 nm. These changes decay very slowly. The illuminated sample (fig. 
2.6, bottom) has a smaller 'M' and a larger increase at 550 nm. Again these changes 
persist even 200 ms after the flash. 
Figure 2.4 shows the proton release and reuptake for S. after an actinic flash 
measured with the pH sensitive dye, pyranine. Under these conditions proton reuptake 
kinetics were close to those of the decay of 'M'. Similar results were seen for the 
analog pigments from.6. (fig. 2.5), but the proton pumping was reduced from that 
observed in the regenerated bacteriorhodopsin (fig. 2.4, right). These results are 
summarized in figure 2.10. 
Extraction of the tritiated retinals from irradiated and non-irradiated samples of the 4-
oxoretinal S. analog pigment showed that -3% (97.4±O.8% extracted-irradiated, 
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97.3±O.8% extracted-non-irradiated) of the radiolabel remained with the protein in all 
cases, regardless of light exposure. 
The data pertaining to the characterization of the rest of the retinal analogs and the 
BR analog pigments derived from them are summarized in fig. 2.10. These data are 
supported by several hundred UV-vis absorbance spectra recorded and analyzed over 
the course of these studies. Several of these spectra are presented in appendix 1. The 
results from these characterizations are summarized below and are discussed in the 
subsequent section with particular emphasis on the retinal analogs that were shown to be 
particularly promising as BR photoaffinity labels. 
VBN-J and VBN-// (8 and 2J. VBN-I (.8.) was synthesized in very limited 
quantities and is very unstable. The analog has a Amax of 360 nm in ethanol and fairly 
rapidly forms a BR analog pigment with a Amax of 472 nm which reversibly light/dark 
adapts. VBN-II (2.) has a Amax of 370 nm in ethanol and fairly rapidly forms a BR 
analog pigment with a Amax of 480 nm. This analog pigment is fairly stable to 
competition with ATR and hydroxylamine. The analysis of the functional capabilities of 
this analog pigment is shown in figure 2.9 which should be compared with the same 
analysis for regenerated BR (fig. 2.7). This analog pigment shows a small 'M'-type 
intermediate at 1 ms after the flash. The '0' intermediate is minimally present at best. 
The 'M' decay kinetics are similar to those of regenerated BR. However the 
measurement of proton pumping showed no indication of proton release/reuptake as 
measured by the pH sensitive dye, pyranine. Also it can be seen that the irradiated and 
non-irradiated pigment are virtually identical in these analyses. This compound was not 
available in radiolabeled form. 
Fred (2). Compound l.!l was nicknamed 'Fred.' It has a Amax of 369 nm in 
ethanol and fonns a BR analog pigment at only 460 run. This analog pigment was 
unstable to ATR and hydroxylamine. 
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TF4N3 (11 ). Tetrafluoro-4-azidoretinal was extremely difficult to synthesize and 
characterize. This compound has a Amax of 390 nm in ethanol and rapidly fonns a BR 
analog pigment at 517 nm which pennanently shifts to 510 nm after irradiation at 350 
nm. The functional characterization of this pigment is shown in fig. 2.8. This analog 
pigment shows a substantial 'M' -like intennediate at 1 ms after the flash and a less 
obvious, but significant '0' -like intennediate at 5 ms after the flash. The kinetic spectra 
show robust formation of the 'M' -intermediate and substantial proton pumping 
estimated to be about 40% that of BR (fig. 2.7). 
Acyclicretinal (1 2 ). Compound II has a Amax in ethanol of 360 nm; not unusually 
low, considering it has one less double bond. The analog BR pigment forms fairly 
rapidly at 450 nm. This pigment is fairly stable to competition with ATR and 
hydroxylamine. 
Compounds U,14. and U. These compounds were synthetic intennediates in the 
syntheses of the above compounds. Their characteristics as BR analog pigments are 
included here since they are novel retinal analogs and for completeness. Their 
characteristics are summarized in figure 2.10. 
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Discussion. 
Khorana, Nakanishi1 and Nakanishi2 (l,l,1.). The characteristics of these three 
retinals and their BR analog pigments are included for comparison to the presently 
studied analogs. Compound Z. is an aromatic retinal analog without the methyl groups 
on the ring. Huang et ale (1982) did not report on the ability of this analog pigment to 
function (i.e. to pump protons). Interestingly, it was Boehm et ale (1990) who reported 
that this BR analog pigment was "nonfunctional". Compound i does however have an 
excellent photoactivatable group in the diazirine. Compound l was more recently used 
to photoaffinity label BR by Ding et al. (1990). This non-aromatic retinal analog is very 
similar to retinal. The analog pigment fonned with this compound does pump protons 
at about 50% - 100% the efficiency of native BR [Sen et al., 1982; Ding et al., 1990]. 
Compound! was also recently reported from Nakanishi's laboratory. This compound 
was shown to form a stable BR analog pigment that was capable of pumping protons at 
about 1/5 the efficiency of native BR [Boehm et al., 1990]. The characteristics of these 
retinal analogs and their BR analog pigments are summarized in fig. 2.10 along with the 
original data for the other retinal analogs derived from this work. The sites labeled by 
these three retinal analogs are analyzed by molecular modeling as described in chapter 4. 
4-0xoretinals (~{, 7). The formation of structurally altered retinals from the 
prolonged exposure of all-trans retinal (or retinol) to manganese dioxide has been 
previously reported. Wald (1948) observed a product he tentatively identified as 4-
oxoretinal. Recently, Colmenares and Liu (1991) report the loss of a carbon in the side 
chain upon reaction of retinal with excess manganese oxide. In this laboratory we have 
isolated three compounds from this reaction, one of which is the 4-oxoretinal as 
reported by Waldo 
The oxoretinals fonn stable BR pigments. The increased rate of formation of the 
dioxocyclopentenylretinal 7 pigment as compared with the other two oxoretinals 5.. and 
6 pigments may be due to the 6-s-trans conformation in solution found in 7 in contrast 
to the 6-s-cis solution conformation of the other two oxoretinals and to all-trans retinal 
itself [Honig et al., 1971]. The native chromophore in BR has been established to be in 
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the 6-s-trans conformation [Creuzet et ai., 1991]. The small opsin shift (2600 cm- i ) 
calculated for pigment 2 may be due to a similar solution and pigment conformation. 
These derivatized retinals ~, .6.. and 7 are in the binding site of the native 
chromophore in BR as shown by the failure of added all-trans retinal to produce a 
pigment at 560 nm. These analog pigments, similar to BR, are also stable to 
hydroxylamine. The absorbance data for the oxoretinal ~ analog pigment are in 
agreement with that previously reported [Sumper and Herrmann, 1976]. The 40-50 nm 
blue shifts in these three oxoretinal analog pigments can be explained by a disruption of 
the interaction of the conjugated double bond system with the texternal point charge' by 
the electronegative substituents on the ring of the retinal analogs at position 4. The 
similarity between the two pigments based on oxoretinal ~ and oxoretinal 6. indicates the 
lack of importance of the double bond between carbons 2 and 3, further supporting the 
notion that an 'external point charge' interacts with retinal near the 4 position. 
These analog pigments have an unusual response to white light showing a 
significant, permanent blue shift rather than the well known metastable red shift 
associated with light adaptation of native BR (fig. 2.3). Once transformed by white 
light, the oxoretinal ~ and oxoretinal .6. based pigments show a metastable red shift 
upon dark adaptation of 4-8 nm which is reversible (fig. 2.2, 2.3). To our knowledge 
these are the fITst bacteriorhodopsin pigments known to light and dark adapt 
'backwards'. The irradiated and non-irradiated forms of ~ and 6. show flash induced 
difference spectra (fig. 2.4, 2.5) similar to BR. However, the 'M' -intermediate decay 
kinetics and proton uptake (fig.2.4, 2.5) are much slower than in BR. 
It was initially thought that this permanent shift induced by white light of pigment ~ 
might be due to the chromophore ring crosslinking with the protein. However, the 
extent of radiolabel in retinal extractions from these pigments is equal and near 
quantitative for photolysed and non-photolysed samples which does not support the idea 
that a crosslink had formed. If crosslinking to the protein has occurred, the linkage is 
evidently unstable to the extraction procedure. 
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Further investigation into the photochemistry of the 4-oxoretinal analog indicates 
that it was unlikely to be a good photoaffinity label due to the relative lack of reactivity 
of the photoactivated intermediate derived from this highly conjugated keto compound 
[Calvert and Pitts, 1966]. Photolysis would yield the n->1t* transition at long 
wavelengths (low energy) for this ketone in conjugation with the extended 1t system of 
the retinal sidechain. This transition would be of considerably lower energy than the 
photoactivated intermediate of the a-~ unsaturated keto steroids that have only one 
double bond in conjugation with the ketone. Besides this low reactivity the radical 
formed would have to undergo an intersystem cross in order to label the protein. This 
intersystem cross is required for spin coupling of the radical pair in the mechanism of 
labeling by these types of compounds (see fig. 1.7) The extra time required for this 
intersystem cross would likely move the radical pair away from each other leading to a 
second hydrogen abstraction instead of combination of the radical pair. It would also be 
possible for the radical derived to be delocalized throughout the extended conjugation 
which could lead to reactivity at any number of carbons. A final consideration is that the 
low energy photoactivated analog may simply decay back to the ground state without 
undergoing any type of intermolecular reaction. Thus, in retrospect, the extended 
conjugation of this retinal analog renders it unlikely to form a highly reactive 
intermediate on photolysis. 
Williams and Mani (1991) speculated that the a,p-dicarbonyl moiety of 
dioxocyclopentenylretinall is similar to arginine modifying reagents making it 
potentially useful as a chemical crosslinking reagent. The unusual irreversible shift 
upon exposure to white light and the unusual 'M' -intermediate spectra (fig. 2.6) of the 
oxoretinall analog pigment may be indicative of a photocycle dependent modification. 
This notion of an analog pigment covalently linked to the protein at both the Schiff base 
and ring end of the retinal would be consistent with its unusual properties. However, 
using 7 tritiated at C-11 and C12, we consistently extract -95% of the retinals from both 
illuminated and non-illuminated analog pigments. The failure to demonstrate 
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crosslinking may be due to the inability of the dioxocyclopentenylretinal to fonn 
crosslinks under the conditions tested or to the instability of a crosslink to the extraction 
conditions. 
VBN-I and VBN-II (£ and 2). VBN-I was made in very limited quantities, is very 
unstable, and possesses an un substituted aryl azide. Because of these drawbacks, it 
was not further evaluated. VBN-II is a very stable compound that has an excellent 
photoactivatable group - the carbene precursor, trifluoromethyldiazirine [Bayley, 1983]. 
This compound forms a good BR analog pigment which, unfortunately, does not pump 
protons to any appreciable extent (fig. 2.9). This lack of function is not unusual for 
aromatic retinal analogs [Crouch, 1986]. There is also no indication of change in 
characteristics between the irradiated and non-irradiated pigments. The need for 
radioactively labeled retinal analogs to assess crosslinking limited the further usefulness 
of this compound for these studies. 
Fred (1 0). This compound possesses a good photoactivatable group (the 
trifluoromethyl-2-diazopropionyl moiety), but forms a very unstable BR analog 
pigment. This lack of stability indicates a poor interaction with the retinal binding site. 
However, the absorbance shift from 369 nm to 460 nm from the chromophore in 
solution to the BR analog pigment indicates at least a partial binding. These indications 
of only a minimal interaction with the retinal binding site encouraged the discontinuation 
of the analysis of this compound. 
TF4N3 (11 ). This compound proved to be one of the most difficult to synthesize 
and characterize, but was promising due to its excellent photoactivatable group [Keana 
and Cai, 1988] and its unusual ability as an aromatic retinal analog, to form a partially 
functional BR analog pigment. The large opsin shift (from 390 nm in solution to 517 
nm as the BR analog pigment) showed the interaction of this retinal with the native 
retinal binding site. The BR analog pigment formed with this compound was also stable 
to competition with ATR and to bleaching with hydroxylamine in the dark. These 
characteristics as well as a 40% proton pumping efficiency indicate that this retinal 
analog is binding well to the native retinal binding site. This retinal analog eventually 
was available in a radiolabeled fonn and was further characterized for its ability to 
crosslink to BR under different photolysis conditions (see Chapter 5). 
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Acyclicretinal (12). This compound contains an excellent photoactivatable group 
(trifluorodiazopropionate, Chowdry et al., 1976) and is not aromatic. It has been 
previously shown that acyclic retinals can fonn functional BR analog pigments [Crouch, 
1986]. This compound was only recently synthesized and will be evaluated for its 
ability to crosslink to organic solvents and when prepared in a radiolabeled form to 
crosslink to BR. 
Compounds 13.14. and lie These three aromatic analogs were analyzed to help 
to detennine if the final product of the syntheses would likely form functional BR 
analog pigments. As is the case with most aromatic retinal analogs, these three 
compounds fonned analog pigments that did not function well. Compounds II and II 
fonned unstable analog pigments as did the final product of this synthesis Fred C1J!). 
The pentafluororetinal (U) analog pigment functioned less well than its azide 
substituted derivative TF4N3 (ill. The analog pigment absorbance maximum of U 
was >50 nm different from that of 11 which allowed a simple use of BR pigment 
formation to test for the successful substitution of the para-fluorine with azide from the 
pentafluororetinal in a different synthetic scheme than that presented in the appendix. 
In summary, the most useful of these retinal analogs for further study is the 
radiolabeled form ofTF4N3 (11). 4-0xoretinal (i) and 2,3 dehydro-4-oxoretinal ~), 
although potentially photoactivatable, show no indication of stable crosslink formation 
to the protein despite their unusual pigment characteristics. VBN-II (2) is an excellent 
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Figure 2.2 UV -vis Spectra of Oxoretinals and Analog Pigments 
Top panel: Absorbance spectra of oxoretinals ~,.6.,1 in ethanol. Middle panel: 
as BR analog pigments in water. Spectra have been normalized. Bottom panel: 
Absorbance spectra of BR analog pigment S. before illumination (a), after 
illumination (b), and illuminated/dark adapted (c) . 
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Figure 2.3 Pattern of LA/DA for Oxoretinal Analog Pigments 
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Figure 2.4 4-0xoretinal Pigment Kinetic Spectra 
Right side: Flash induced absorbance changes of regenerated BR and oxoretinal S. ba ed pigment 
after irradiation with white light. The traces were normalized at their maxima to facilitate 
comparison of the kinetics. Left side: Flash induced absorbance changes of 5 based pigment without 
irradiation with white light. Top panels: Flash induced difference spectra 1 ms after the actinic 
flash. Middle panels: 'M'-type intermediate kinetics measured at 410 nm. Bottom panels: Proton 
release and reuptake as detected by absorbance changes in the pH sensitive dye, pyranine. 
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Figure 2.5 2,3-dehydro-4-oxoretinal Pigment Kinetic Spectra 
Right side: Flash induced absorbance changes of oxoretinal ~ based pigment 
after irradiation with white light. Left side: Flash induced absorbance changes 
of ~ based pigment without irradiation with white light. Top panels: Flash 
induced difference spectra 1 ms after the actinic flash. Middle panels: 'M'-type 
intermediate kinetics measured at 410 nm. Bottom panels: Proton release and 
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Figure 2.6 Dioxocyclopentenylretinal Kinetic Spectra 
Flash induced difference spectra of oxoretinal 7 based pigment. Top panel: 
non-irradiated, 1 ms (left spectrum) and 200 ms (right spectrum) after the 
actinic flash. Bottom panel: irradiated, 1 ms (left) and 200 ms (right) 
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Figure 2.7 Regenerated Bacteriorhodopsin Kinetic Spectra 
Flash induced absorbance changes of regenerated BR as positive 
control for those in figures 2.8 and 2.9. a) Difference spectrum 
1 ms after flash, the 'M' intermediate. b) Difference spetrum 5 
ms after the flash, the '0' intermediate. c) Flash induced 
absorbance change at 410 nm, 1M' intermediate kinetics. d) Proton 
release and reuptake as detected by the pH sen itive dye, pyranine. 
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Figure 2.8 TF4N3 Pigment Kinetic Spectra 
Flash induced absorbance changes of TF4N311 analog 
pigment before (a+b, Left) and after (a+b, Right) 
irradiation at 350 nm for 10 min in the RPR-IOO. 
a) Difference spectra 1 ms after flash. b) Difference spectra 5 
ms after the flash. c) Flash induced absorbance change 
at 410 nm, (I-irradiated, 2-dark) d) Proton release and 
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Figure 2.9 VBN-II Pigment Kinetic Spectra 
Flash induced absorbance changes of VBN-II 9 analog 
pigment before (a+b, Left) and after (a+b, Right) 
irradiation at 350 nm for 10 min in the RPR-IOO. 
100 
a) Difference spectra 1 ms after flash. b) Difference spectra 5 
ms after the flash. c) Flash induced absorbance changes 
at 410 nm, (I-irradiated, 2-dark) d) Proton release and 







Chromophore Name ABS Max EtOH PSB ABS Max EtOH Pigment tl(2 formation Stability M ~ intermediate Proton Pumping 
DAlLA NH20H/ATR ABS Max 
Retinal 378 444 558/568 *** ***/*** 412 *** 
2 Khorana 370 N/A 470 N/A N/A N/A N/A 
3 Nakanishi 1 380 N/A 525 N/A N/A 410 ** 
4 Nakanishi2 385 N/A 497 N/A N/A N/A ** 
5 4-Oxoretinal 378 425 524# ** **/** 420 * 
6 2,3 Dehydro-4-oxoretinal 380 426 522# ** **/** 420 * 
7 Dioxocyclopentenylretinal 435 455 515 # *** **/** unusual 0 
8 VBN-I 360 N/A 472/478 ** N/A N/A N/A 
9 VBN-IT 370 N/A 480 ** **1** 400 0 
10 FRED 369 N/A 460 ** *1* 390 * 
11 TF4N3 390 unstable 517 *** **/** 400 ** 
12 Acyclicretinal 360 N/A 450 ** */* 
13 Pen tafluororetin al 360 407 456 ,.. *1* unusual * 
14 Hydroxyretinal 386 456 491 * */* 390 * 
15 Methoxyretinal 382 450 490 ** */* 390 * 
Figure 2.10 Summary of characteristics of retinal and retinal analogs and their BR pigments. N/A= not available. 
Data for Khorana is from Huang et aI., 1982, for Nakanishi 1 , from Ding et al., 1990 and for Nakanishi2, from Boehm et al., 1990. 
# see fig. 2.3. 
Chapter 3 
Model Photolysis 
Portions of this chapter have been published as 
Beischel, CJ, SK Moore, RK Crouch, and DR Knapp. 
"A Versatile Flash Photolysis Apparatus." 
Rev. Sci. Instrum. 63(3), 2069-2072, 1992. 
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Introduction. 
Once the BR analog pigment is formed and characterized it is necessary to 
photoactivate the analog to produce the reactive intennediate and effect labeling of the 
protein. The reactive intennediates are usually products of the loss of molecular 
nitrogen from different photoactivatable moieties. Photoactivated diazirines and 
trifluorodiazopropionates form carbenes; aryl azides and fluorinated aryl azides fonn 
nitrenes. These highly reactive intennediates are capable of C-H bond insertion, other 
stable bond formations and unstable formations. In order to efficiently photoactivate the 
retinal analogs described in Chapter 2, it is important to determine the appropriate 
photol ysis conditions. 
These experiments are commonly done using continuous wave irradiation of 
samples with UV light. Photoactivation of reagents is often accompanied by 
nonspecific photolytic or heat induced damage to the protein or other biological system 
under study, especially if the wavelength of irradiation corresponds with the absorbance 
of the protein. It has been observed that the use of flash photolysis in place of CW-UV 
irradiation causes less protein damage [Ii, 1979]; therefore, the use of flash photolysis 
can be advantageous in such experiments. 
Short duration UV flashes can be obtained from gas discharge flashlamps or 
from UV lasers. Flashlamp sources are significantly less expensive than laser sources. 
Commercially available photoflash units have been used for flash photolysis 
experiments [Kiehm and Ii, 1977]. Larger photon fluxes can be delivered with shorter 
duration flashes using xenon flashlamps fired by high voltage power supplies and rapid 
discharge capacitors, but this type of apparatus can present greater safety hazards in the 
laboratory in terms of potential for UV exposure, flashlamp explosion, and electrical 
shock. A xenon flashlamp apparatus is commercially available including flashlamp 
enclosures with mirror and lens assemblies to yield focused beams of light (e.g., from 
Xenon Corporation, Woburn, MA). A sample cell where the sample solution is 
contained in an annular chamber surrounding a linear flashlamp has been described 
[Matheson, et al., 1977]. This type of apparatus has the advantage of giving uniform 
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exposure of the entire sample and of making maximal utilization of the UV light. 
Believing that such an apparatus would be effective in activating the retinal analogs 
described in Chapter 2 and being unable to locate a commercial source, an apparatus 
was designed and constructed. Design elements include a lamp enclosure/sample cell 
incorporating safety features to minimize the potential hazards from UV exposure, lamp 
explosion, and electrical shock and the versatility to use chemical solution futers and 
temperature control. The sample cell design incorporates a series of concentric annular 
chambers of different path lengths (1 mm or 2 mm in the present design) which can be 
used for sample solutions, circulating temperature control fluids, or wavelength 
selecting filter solutions. The lamp enclosure/sample cell was used with a commercially 
available power source, but designs for construction of suitable power sources have 
been reported [e.g., Wegrzyn et ai., 1989]. This chapter describes the lamp 
enclosure/sample cell and compares it with a commonly used CW source in tenns of 
photon flux as measured by chemical actinometry and photolysis of a model aryl azide 
compound (fig. 3.1 and 3.2). 
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Materials and Methods. 
Materials. Ferric chloride, potassium oxalate monohydrate, ferrous sulfate, sodium 
acetate, sodium azide, cyclohexane, pentafluorobenzaldehyde, dimethylformamide and 
1,10-phenanthroline were reagent grade (Aldrich, Milwaukee, WI) and used without 
further purification. The organic solvents were stored over molecular sieves. 
Tetrafluoro--4-azidobenzaldehyde (TFABA) was prepared by a mcxlification of the 
method of Keana and Cai (1988). Pentafluorobenzaldehyde was allowed to react with a 
1.5 molar excess of sodium azide in dimethylfonnamide for 6 hours at room 
temperature [Beischel et aI., 1990]. The product was confrrmed as TFABA by uv, IR, 
and gas chromatography-mass spectrometry (fig. 3.2, top panel). 
Continuous wave apparatus. A Rayonet Photochemical Reactor RPR-100 (New 
"-
England Ultraviolet), equipped with sixteen type 3500A lamps (350 nm) was used with 
the same sample cell as used in the flash apparatus (see below). 
Flashlamp and power source. A Xenon Corporation (Woburn, MA) Model 
N-734D line source flashlamp was used. This linear flashlamp has a 3 mm bore and a 
75 mm arc length. The flashlamp was fired by a Xenon Corp. Model M-457 A 
Micropulser configured with a 0.2 F capacitor to deliver 10 J at 10 kV and having a 
repetition rate of up to 30 Hz. For the experiments described here, 10 J flashes were 
employed under manual control. 
Flashlamp housing and sample cell. (This apparatus was designed by Daniel R. 
Knapp and constructed by Cliff Harvey.) The flashlamp housing and sample cell are 
shown in fig. 3.4. The housing is constructed from 5 in outer diameter, 0.125 in wall 
aluminum tubing (A) mounted on a 9 in x 7 in x 2 in aluminum chassis (B) with a disc 
of 0.75 in thick bakelite (C). The interior of the aluminum tubing is polished to give a 
reflective surface. Another disc of bakelite forms a cover (D) on which is mounted the 
connector removal mechanism and safety interlock switches (E,F) (Microswitch SM 
series subminiature switches, Newark Electronics, Chicago, IL). The chassis bottom is 
covered with a sheet of 1/4 in Plexiglass. Switch E is closed when the enclosure cover 
is in place, and switch F is closed when the flashlamp power connector is in place. 
3-5 
Switches E and F are wired in series with the safety interlock circuit of the M-457 A 
Micropulser which prevents the fIring of the flash circuit unless both the cover is on and 
the connector attached. The flashlamp (G) is mounted at the bottom end (flashlamp 
cathode) in a Superior Electric Supercon type RS50GR receptacle (Newark Electronics, 
Chicago, IL) which has been drilled out for a tight fit on the 0.280 in Flashlamp end 
terminal. This connector is connected with 14 ga copper wire to a Supercon type 
RP50GR pin connector mounted on the chassis base (H). The connections are covered 
with RTV Silicone Rubber (Newark Electronics, Chicago, IL) to reduce corona 
\ 
discharge. The chassis pin connector mates with the socket connector on the cable 
supplied with the Micropulser. The top flashlamp terminal connects to a custom made 
0.280 in brass collet mounted in the enclosure cover. The collet is tightened with the 
threaded pin taken from a S upercon RP50GR connector using a hollow 7/16 in 
nutdriver (XceLite RS-14). The pin then connects to the Supercon RP50GB connector 
on the Micropulser cable. The cable connector is mounted in a Delrin cylinder with 
exterior grooves machined to match levers (I) taken from a household corkscrew device. 
The levers are used to remove the tightly fitting connector. 
The sample cell (detail shown in fig. 3.5) is constructed from four 65 mm lengths 
(J) of concentric quartz tubing (Quartz Scientific, Fairport Harbor, OR). Tubing 
sizes of 15 mm id, 18 mm ad; 22 mm id, 25 mm od; 27 mm id, 30 mm od; and 34 mm 
id, 37 mm od give three concentric cylindrical chambers 2 mm, 1 mm, and 2 mm thick. 
The lengths of tubing are press fitted into 2.5 mm deep grooves in end pieces (K) 
machined from 1/2 in thick Teflon discs. Each endpiece contains an 11 mm diameter 
center hole through which passes the flashlamp. Connections to the chambers are made 
through 1/4-28 threaded holes (L) designed to mate with flange type tubing connectors 
(Alltech No. 2022, State College, PA) or plugs (Alltech No. 80089). A cylindrical 
support (M) cut from a plastic beaker holds the cell at the proper height to align with the 
flashlamp arc. 
F errioxalate actinometry. The dose of UV radiation delivered to the 1 mm sample 
compartment by the continuous wave and flash sources was compared using potassium 
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ferrioxalate (KFOX) actinometry as described by Hatchard and Parker (1956) (fig. 3.1, 
top). Several suggested modifications to this original procedure were incorporated and 
tested using standard ferrous solutions (Calvert and Pitts, 1966; Kurien, 1971; Cabral 
--et al., 1977; Boman and Demas, 1981; Kirk and Namasivyam, 1983) (fig. 3.3, top). 
The cell was filled with 0.15 M KFOX (0.1 N H2S04) and exposed to either CW or 
flash' UV radiation. Aliquots (20 J.1l) were removed after various amounts of UV 
exposure (time for CW source; number of flashes for flash source) and allowed to react 
for one hour with the following: 1,10-phenanthroline (400 JlI, 1 %, 0.025 N H2S04; 
7-fold molar excess over 0.15 M ferric/ferrous ion concentration), 1.5 M sodium 
acetate (30 JlI), 0.05 N H2S04 (550 JlI). The absorbance at 510 nm was measured 
using a Varian CARY 2200 spectrophotometer using the same mixture minus the KFOX 
as reference. 
Photolysis ofTFABA. A 1.5xlO-7 M solution ofTFABA in cyclohexane was 
exposed to either the CW or flash light source. Periodically in time or number of 
flashes, samples of the solution were analyzed by gas chromatography-mass 
spectrometry (Hewlett Packard 5970B) to detennine the amount of the cyclohexane 
addition product, (fig. 3.2, bottom) 4-cyclohexylaminotetrafluorobenzaldehyde 
(TFCBA) fonned. 
Photolysis of pigments. Bacteriorhodopsin analogs and pigments are irradiated in 
the same sample cuvettes as described above. The pigments are kept cold by placing the 
RPR in the cold room and filling the center of the sample cell with ice.. At all times the 
sample is separated from ice cold water by only a 1 mm thick quartz cylinder. The 
sample cell is cooled in the flash apparatus by placing the cell in a plastic beaker that has 
had a hole cut in the bottom. The beaker is then filled with ice and again the sample is 
always separated from ice cold water by only a 1 mm thick quartz cylinder. 
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Results. 
The photon dose measur~d by KFOX actinometry was plotted versus time or 
number of flashes and found to be linear with time in the CW source up to 
approximately 50 s exposure and with number of flashes in the flash source up to about 
25 flashes. Under the conditions used, the photon doses measured in the linear region 
were 7.3 x 1017/s for the CW source and 7.6 x 10 17/flash for the flash source (fig. 
3.3, bottom). 
The photolysis of TFABA, as indicated by the production of the cyclohexane 
insertion product TFCBA, reached a maximum after about 40 s of CW irradiation and 
after about 10 flashes. No other significant products were observed indicating near 
quantitative conversion of the TFABA to the cyclohexane insertion product. See fig. 
3.6 for an example of the GC-MS data. 
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Discussion. 
The apparatus depicted in fig. 3.4 provides a convenient, safe, and versatile 
method of performing flash photolysis experiments on solutions and incorporates 
provisions for temperature control via circulating thermostatted fluids and the use of 
solution wavelength futers. Key design features in the described apparatus were for 
protection of the operator from the hazards of UV exposure, lamp explosion, and 
electrical shock. The lamp and sample cell are enclosed in a light tight cylindrical 
container which also provides protection in the event of lamp explosion. The cover 
plate, while light tight, is loose fitting and would be blown off in the event of explosion 
and allow debris to be directed vertically. Safety interlock switches which are wired in 
series with the safety interlock circuitry of the Micropulser unit prevents activation of the 
high voltage circuitry unless the cover is on the enclosure and the top electrical lead is 
attached. A key feature of the apparatus is the collet type upper flashlamp terminal 
connector. Insertion and removal of the concentric sample cell requires opening of an 
electrical connection to the flashlamp. Due to the requirement for a high current, low 
resistance connection, the connectors supplied on the Micropulser cables require a tight 
force fit. Repeated attachment and removal of such a connector presents a risk of 
breakage of the relatively expensive flashlamp. We therefore employed the concept of a 
"zero insertion force" connector which is tightened after insertion with no stress applied 
to the lamp tenninal. This was accomplished by machining a brass collet, similar to 
those used on machine tools, sized to fit the 0.28 in lamp terminal. The collet is 
tightened with a 1/4-28 threaded hex bolt/connector pin (part N in fig. 3.4) from a 
Supercon type pin connector. The connector pin mates directly with the Supercon 
connector on the Micropulser cable. Since this high current connection also fits tightly, 
a means of removing it without transferring stress to the flashlamp was needed. A 
removal mechanism was fabricated using lever arms from a household corkscrew device 
to remove the connector with a smooth vertical force. 
The photon flux delivered to the sample cell by the flashlamp was compared to 
that delivered to the same cell in a commonly used CW irradiation apparatus using 
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KFOX actinometry. Lamps delivering predominant radiation centered around 350 nm 
were used in the CW source since this wavelength is commonly used to photolyze 
electronegatively substituted aryl azide compounds and diazirines. The quantum yield 
of the KFOX actinometer and the emission characteristics of the two light sources as a 
function of wavelength are shown in fig. 3.5, bottom. The actinometry measurements 
showed that the total flux delivered in 1 sec of CW exposure could be obtained from a 
single flash with 10J delivered to the flashlamp. Since the duration of the flash is on the 
order of 2 Jls, the flash source is more than 105 as intense per unit time. The sample 
exposure, therefore, is less than 10-5 as long with the flash source as with the CW 
source for the same UV flux delivered. 
Since fluorinated aryl azides have been suggested as excellent photoactivatable 
groups and since TF4N3 retinal (8.) possesses this functionality, photolysis of a model 
fluorinated arylazide (TFABA) was used as a model to compare the CW and flash 
sources. Photolysis of TFABA in cyclohexane yields a single C-H insertion product, 
TFCBA. The maximum production of TFCBA required about 4 times the photon flux 
from the CW source as from the flash. This result suggests that the nominal 350 nm 
lamps in the CW source do not deliver the optimal wavelength for photolysis of the aryl 
azide. In summary, the described apparatus provides a convenient, versatile, and safe 
means of employing high flux, short duration flash photolysis on solution samples. 
It requires five times the number of flashes needed to activate the model 
compound to induce noticeable damage to the protein. However, at even very long 
exposures to the CW source using 350 nm light, no noticeable protein damage was 
detected. These results suggest that the protein damage is done by short wavelength 
light which is further supported by the fact that 254 run wavelength bulbs in the Rayonet 
Reactor sharply decreased the absorbance of BR at 570 nm over only fifteen minutes 
irradiation (data not shown). It may be possible to replace the expensive quartz 
cylinders in the sample cell with Pyrex cylinders. Pyrex glass absorbs light < 300 nm 
and is less fragile than quartz. Since photoactivation can be induced by light> 300 nm 
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in wavelength, as shown by the CW source, glass cylinders may be an inexpensive 
alternative to the easily broken quartz cylinders. The shielding of the sample from light 
< 300 nm may also decrease protein damage. 
As evidenced in the emission spectra in fig 3.5, the flash apparatus has a wide 
emission spectrum with high flux in the UV «340 nm). With these characteristics, the 
flash apparatus should activate nearly any of the photoactivatable groups described here. 
The RPR-IOO reactor with the 350 nm bulbs should activate the fluorinated arylazides 
and diazirines very specifically with less damage to protein than the flash apparatus. 
These two sources were used in attempts to photoactivate TF4N3 as described in 
Chapter 5. 
Act i n () met r y 1\1 e t h () d 
hv 
Fe3 + -----~~ Fe 2 + 
510 nm 
Figure 3. I Actinometry 
Diagranl of chemical actinometry method. Potassiunl ferrioxalate solution 
absorbs light converting ferric ion to ferrolls ion which is conlplexed by 
1,10 phenanthroline. This 3: 1 conlplex is red (510 nI11). 
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Figure 3.2 Model Photolysis 
Top panel: Synthesis of tetrafluoro-4-azidobenzaldehyde 
from pentafluorobenzaldehyde with sodium azide. 
Successful synthesis was confinned spectrally. 




TF4ABA in cyclohexane leading to the desired C-H insertion 
derived cyclohexane addition product, TFCBA. 
F 
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Figure 3.4 Flash Apparatus 
Diagram of coronal section of flash photolysis apparatus. 
See text for descriptions of lettered items. 
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Figure 3.5 Sample Cell and Enlission Spectra 
Top panel: End view and cross-sectional view of sample cell depicted in 
figure 3.4. The end view shows access points to the different annular 
chambers formed by the four quartz cylinders that fit tightly into grooves 
in the top and bottom teflon bases. Bottom panel: Emission spectra of the 
flash lamp (heavy dashed line), the RPR- l 00 350 nm lamps (solid line) , 
and the quantum yield of the actinometry method (light dashed line). 
Emission spectra adapted from manufacturers' literature. Quantum yield 
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Figure 3.6 Example of Model Photolysis Results 
This figure shows the gas chromatography - mass spectrometry 
confirmation of the C-H insertion derived product from the photolysis 
of TF4ABA in cyclohexane. GC-MS data from the 30 s time point 
indicating --60% conversion of the azide (TF4ABA, 4.2 min, 
mass=219) to the cyclohexane addition product 









Bacteriorhodopsin has 248 amino acids, each of which is at least potentially a 
site of labeling for photoactivatable retinal analogs. It is important to be able to predict 
and interpret the many possible labeled sites. Predictions define the expected 
experimental results as a small set of amino acids likely to be labeled. These predictions 
fonn the basis of the hypothesis that a photoactivatable retinal analog in the native retinal 
binding site will label one or more of the amino acids in the set. Interpretation includes 
whether experimental results are consistent with the predictions and evaluation of the 
models used to make the predictions. The use of sophisticated computer programs for 
molecular graphics allows insights and measurements on these complex molecules as 
well as building of accurate models of less complicated molecules such as retinal 
analogs. The tools of molecular modeling are used to visualize this complex protein and 
to predict experimental results. 
Henderson et al. (1990) published and subsequently deposited in the 
Brookhaven protein crystal data bank coordinates of a molecular model for BR based on 
cryo-electron diffraction studies. This widely accepted model serves as the basis for the 
following predictions. 
By using Henderson's model in our dynamic, room temperature system it is 
possible to test the accuracy of this model that is based on studies done at 4 K on 
partially dehydrated PM. To keep the interpretation of these types of studies simple, it is 
important to make as few assumptions as possible. If amino acids are labeled that are 
outside the predicted sets, it implies that the predictions were incorrectly made, that the 
model is poor or that the labeling experiment did not work as planned. Three 
increasingly restrictive assumptions were made as to the placement of the retinal analog 
in the native retinal binding site of BR. Each assumption requires the retinal analog to 
be more and more precisely restricted to the native retinal binding site. These methods 
are applied to four different photoactivatable retinal analogs. 
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Materials and Methods. 
Materials. The necessary equipment for these studies include a desktop computer 
(Macintosh IIsi) networked to the university VAX 11n85 and the Biomolecular 
Computing Resource software that includes the molecular modeling software SYBYL 
by Tripos (St. Louis, MO). The desktop computer must also run the tenninal emulation 
application for SYBYL, NITRO (Tripos). For graphics manipulation on a smaller scale 
and for a variation on graphics output, an application called Nanovision (ACS Software, 
American Chemical Society, William R Light, generously purchased by DW Corson) 
was used. Slide output was done using Powerpoint (Microsoft) and a Montage 
(Presentation Technologies, Santa Cruz, CA) slidemaker. 
Methods. It is not the intent of this methods section to explain the general use of 
the Macintosh as a tenninal for the Vax or of the SYBYL molecular modeling package. 
Some important commands or subsections of SYBYL particular to this work are 
capitalized and explained in this section. The atomic coordinates of the 
bacteriorhodopsin model of Henderson were imported into SYBYL from the 
Brookhaven crystal data bank (Biopolymer Brookhaven In). The model is fully 
manipulatable in SYBYL. This structure is the working model for these predictions. 
The crystal structure of Vitamin A (retinol) was imported from the SYBYL fragment 
library as was that of lysine (Build Molecule Fragment Fragment_name Get). The 
Vitamin A is in the 6-s-trans configuration as it has been shown to be in the protein 
[Creuzet et al., 1991]. The lysine-retinal protonated Schiff base structure was 
'synthesized' in SYBYL. This basic structure was compared to the same structure lifted 
from the Henderson model. The retinal was then modified to model the photoactivatable 
retinal analogs that have previously been used to label BR and the labels that are being 
synthesized for this project. Using the Measure Distance command in SYBYL the 
distances between different atoms in the modeled analogs were measured. Three 
distances were measured for each analog: from the alpha carbon of the lysine (#1) to the 
photoactivated carbene or nitrene, from the Schiff base nitrogen (#2) to the 
photoactivated carbene or nitrene, and from carbon 6 of the retinal analog (#3) to the 
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photoactivated group (fig. 4.1). These distances were used to define sets of amino 
acids that are within a reasonable distance to be labeled by the photoactivated analogs. 
A large sphere of the distance measured plus 3 angstroms had a smaller sphere of the 
distance minus three angstroms subtracted from it. For example, the SYBYL command 
to define a set of amino acids between ten and fIfteen angstroms from the Schiff base 
lysine is Define Dynamic_Set Substructure {Sphere(Lys216.NZ, 15) }-
{Sphere(Lys216.NZ,10)} Setname Comment. To list the amino acids in the resulting 
set the command List Local Setname Full is used. Any amino acid residue that has an 
atom in this defined volume is made part of the set. This manipulation defmed a set of 
amino acids that were close to the photoactivatable group assuming free movement 
about the atom used for the measurement. Also defined was a set of amino acids on the 
'outside' of the helixes in Henderson's model. This set was defined by choosing an 
amino acid that pointed directly to the center of the bundle and defining its rotation to be 
o degrees. One hundred degrees was added or subtracted for each step in the amino 
acid sequence and any amino acid that was between 101 degrees and 259 degrees was 
determined to be outside the helix and unlikely to be labeled. Each amino acid in the (X-
helix was assumed to be 100 degrees from the preceding amino acid [Stryer, 1988]. 
This set of amino acids was subtracted from each of the predicted sets to leave three 
predicted sets for each retinal analog (Define Static_Set Substructure {Setname}-
{Outside} Setname Comment). In order to more correctly analyze the results of Huang 
et ale (1982), it was necessary to build their labeled amino acids onto Henderson's 
structure. Ser193 and Glu194 were added to Gly192 as an (X-helix and alternatively as 
a random coil (using the Picking menu Biopolymer, Edit Molecule, Add to Chain 
subsections). This was necessary because Henderson's model contains only the amino 
acids for which he had sufficient electron density to model (i.e. those in the 
transmembrane helixes). The two new models were used in the evaluation of the analog 
Khorana l.. 
Movement of molecular graphics fues from SYBYL to Nanovision or most other 
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molecular graphics packages requires the use of the Biopolymer Brookhaven Out 
Filename commands. This series of commands writes the chosen structure from the 
SYBYL format into the standard Brookhaven database fonnat that is readable by 
Nanovision. Graphics output of the NITRO window to a Macintosh PICT file is done 
simply from the File Menu of the NITRO tenninal emulation software. 
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Results and Discussion. 
The amino acids in the set 'Outside' that are predicted to be oriented away from the 
retinal binding site are depicted in an end-on view in Fig. 4.2. The three sets from 
Nakanishi! J. are depicted graphically in figures 4.3-4.6. Set #3 and the labeled sites 
for Khorana l are shown in fig. 4.7 on an especially extended version of Henderson's 
model that contains Ser193 and Glu194 in an Cl helical confonnation. The results of 
labeling with Nakanishi2 i are shown in fig. 4.8 along with the amino acids of set #3 
for this retinal analog. The sequence of BR, the amino acids in the structure, the amino 
acids determined to be outside the barrel of BR, the measurements and the three sets for 
four different analogs are summarized in Fig 4.9. The two models of retinal, one lifted 
from Henderson's model and that obtained from the fragment library are very similar 
and the measurements made on these models were nearly identical (data not shown). 
The model derived from the fragment library was used in the measurements presented 
here. 
The prediction of the labeled sites was made with a minimum of assumptions. 
The first is the use of Henderson's model as the working model. This assumption 
implies the accuracy of this model of BR that was derived from two dimensional 
crystals at liquid nitrogen or liquid helium temperatures. Henderson's model correlates 
well with the rest of the biophysical data derived from studies of BR at various 
temperatures. This includes an excellent correlation with the studies done using site-
directed mutants of BR that have defined certain amino acids that are believed to be 
important for tunirig of the absorbance spectrum of retinal and for proton pumping 
function [Khorana, 1988]. 
The assumption was made that the retinal analogs would fonn a Schiff base with 
Lys216 and not with other amino groups. This assumption is based on the extensive 
literature on BR analog pigments in which the retinal analogs that fonn BR analog 
pigment bind to Lys216. A Schiff base formed with another amino group will not be 
stable because it will not be in the very special environment that surrounds Lys216. The 
4-7 
opsin shift indicates that the Schiff base-retinal link is protonated and that it is being 
influenced by the known counterion. The protonation and counterion contribute most of 
the influence for the opsin shift [Motto et al., 1980]. The BR analog pigments 
described here are stable and display a considerable opsin shift indicating that the 
retinals are interacting with a similar environment as is the native retinal that has been 
shown to be Schiff base linked to Lys216 [Bayley et al., 1981]. 
It is also assumed that since the retinal and the analogs are believed to be in the 
center of the seven transmembrane helixes that the amino acids on the outside (Le. near 
the lipid membrane, the hydrophobic half of the amphipathic helix) will not be labeled 
by the photoactivated intennediate. It is much more likely that the reactive intennediate 
would label a site on the inside. This assumption allowed the exclusion of 69 amino 
acids from the total of 178 amino acids in the structure (fig. 4.2). Note that 70 of the 
original 248 amino acids have been deleted by Henderson's results. He did not model 
the amino acids for which he did not have sufficient electron density. The 70 excluded 
residues fonn the more freely moving extramembranous loops. Ser193 and Glu194 are 
in these loops, but were added in two different motifs in order to more thoroughly 
evaluate the results of Huang et al. (1982). 
Three sets were defined for each retinal analogs. These sets identified amino acids 
that were an appropriate distance from the three centers of rotation to come into contact 
with the photoactivated intennediate (fig. 4.1). The three sets show increasing 
restriction of the movement of the retinal analog in the protein. The three sets were 
defined assuming free movement about the a carbon of Lys216 (#1) allowing the entire 
retinal, Schiff base and lysine sidechain to move, about the Schiff base nitrogen (#2) 
allowing movement of only the retinal, and about carbon 6 of the retinal (#3) allowing 
movement only around the ring end of the retinal analog. This last assumption is 
reasonable because it is believed that the retinal and thus the very similar analogs are 
tightly held by the protein around the retinal side chain [Crouch, 1986]. The second 
assumption relies on the stability of the position of the lysine side chain. The fITst 
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assumption depends only on the stability of the helixes. 
A plus or minus three angstrom volume was chosen for several reasons. 
Measurements on the retinal-lysine combination lifted from Henderson's model varied 
slightly from our model developed from the crystal structures. It is assumed that the 
retinal analogs bind in the 6-s-trans confonnation. Changing this ring-side chain 
orientation can change the measurements on the analogs slightly_ The hydrogen atoms 
are not included in Henderson's structure which gives another approximately one 
angstrom size around most amino acid sidechains. The bond fonned would have a 
length of about 1.5 angstroms. This room for variation led to the choice of a rather 
large volume - 6 angstroms thick - as potentially contacted by the photoactivated 
intennediate. 
The three previously used labels were included in this analysis to test the validity 
of the analysis and the likelihood that these analogs labeled sites in the native retinal 
binding pocket (fig. 4.1). The experiments of Huang et al. (1982) showed the labeling 
of Ser193 and Glu194 (Arrow, fig. 4.7; Boxed and Shaded, fig. 4.9) with an aromatic 
analog of retinal (1). These two amino acids are not in Henderson's model. Since not 
enough electron density was available to model them, they are believed to be part of the 
freely moving extramembranous loops. It is likely [Henderson et al., 1990] that this 
label was incompletely in the binding site consistent with its small opsin shift and the 
unreported functional state of the analog pigment. (It should be noted that Huang et ale 
(1982) did not report the functional characterization of the BR analog pigment formed 
with 2.. However, Boehm et ale (1990) stated that the BR analog pigment fonned with 
l was "nonfunctional".) When this analog was tested with two models of BR that had 
Ser193 and Glu194 built on as a-helix and random coil, these two amino acids were 
still not in the specified volume. In fact, the hydroxyl of the Ser193 was -4 angstroms 
beyond the larger sphere and the terminal oxygen of Glu 194 was -7 angstroms beyond 
the larger sphere (fig. 4.7). These amino acids are 12-16 angstroms from the number 
six carbon of the retinal as placed by Henderson. 
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The experiments of Ding et al. (1990) using the retinal analog (l) showed labeling 
of Thr121 and Gly122 (Arrow, fig. 4.6; Boxed, fig. 4.9). These sites are in all of the 
sets predicted by this analysis indicating the likely placement of this analog in the native 
retinal binding pocket. Since the BR analog pigment of Nakanishi 1 (J) is functional, it 
is believed that this analog fits well into the native site. (It should be noted that Ding et 
al. (1990) reported 100% efficiency in proton pumping of the BR analog pigment 
formed with J. as compared to positive control. Whereas, Sen et ale (1982) stated that 
the analog pigment was 50% functional. This difference could be explained by the use 
of optically pure J. in the experiments of Ding et ale (1990).) 
Evaluation of the labeled sites reported using the retinal analog Nakanishi2 i 
[Boehm et a/., 1990] was more complex. Of the four amino acids labeled (Ala126, 
Leu127, Trp137 and Trp138 (fig. 4.8)), only Trp138 was predicted to be properly 
situated to be contacted by the carbene derived from photolysis of 4. The labeling of 
Ala126 and Leu 127 is particularly interesting since these amino acids possess aliphatic 
sidechains. Assuming labeling of the sidechains, the ability of the carbene to insert into 
the very stable C-H bonds may indicate very close contact between the carbene and 
these sidechains. The limitations of the use of Edman degradation to determine labeled 
sites when fairly high resolution structural infonnation is desired is highlighted by the 
labeling of these two amino acids. Leu127 was labeled, but is oriented, in the model, to 
the outside of the helices where it may interact with the lipid bilayer as one might expect 
for a very hydrophobic amino acid such as leucine. The labeling of these amino acids 
shows a limitation in the model suggesting a rotation of helix D to turn Ala126 and 
Leu127 toward the retinal binding site. Or, as suggested by Boehm et al. (1990), the 
labeling of Leu 127 may arise from incomplete cleavage or elution during each cycle of 
the Edman sequencing when Ala126 primarily contained the radiolabel. They also, very 
reasonably, suggest the movement of the retinal analog in the binding site as reason for 
distribution of the sites of labeling on these two amino acids. The modeling perfonned 
here favors the first argument involving incomplete Edman cycling. However, it should 
be emphasized that neither of these sites is well situated to be labeled by this retinal 
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analog, if the analog binds in the retinal binding site as modeled by Henderson. These 
two amino acids are located very near the cytoplasmic end of helix D indicating that this 
retinal analog, similar to Khorana Z. must be oriented with its ring much closer to the 
cytoplasmic surface than the native retinal. This lack of ability to completely bind to the 
hydrophobic binding pocket of the retinal ring may be due to the addition of the polar 
photoactivatable groups. 
The labeling of Trp137 and Trp138 by Nakanishi2 i is also very interesting. The 
model and the predictions presented here clearly indicate the proximity of the ring of 
retinal to Trp138 in the retinal binding pocket. However, if the previous argument 
about the smearing of the radiolabel in the Edman cycling holds, one must assume that 
the primary labeling was to Trp137. These amino acids are separated by a 100 degree 
rotation around helix E. These inconsistencies emphasize the need for determination of 
the exact amino acid(s) labeled for proper evaluation of labeling in this high resolution 
context. It would be possible to reorient helix E to place the two tryptophans in close 
proximity to the ring end of the retinal. It should be emphasized that small variations in 
the model as suggested by this particular result may not be warranted considering the 
difficulty in interpretation of the data. 
The labeling of these four amino acids by.i and of Ser193 and Glu194 by 1 
indicate the difficulty inherent in the chemical modification of retinal with retention of 
binding to the native retinal binding site. One fairly simple interpretation of these results 
is that these two retinal analogs, due to the modifications of their rings, fit only well 
enough in the retinal binding site to form the Schiff base and that the ring end of these 
analogs was not capable of completely fitting into the retinal binding site. Thus, these 
retinal analogs labeled amino acids between the retinal binding site and the cytoplasmic 
surface of the protein. 
The fact that these amino acids were not identified even in set #1 for each of these 
retinal analogs may indicate an overly rigid interpretation of the model. The assumption 
for set #1 required rigid retention of the relative positions of the alpha helices. It is 
possible that the the bindirig of a retinal analog, that does not fit well into the ring end of 
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the binding pocket, to the epsilon amino group of Lys216 may shift the relative 
positions of the alpha helices allowing contact between the reactive intennediate, still 
tethered to Lys216, with the amino acids that have been shown to be labeled. 
From this discussion, it may be concluded that the retinal analog Nakanishi1 J. fit 
best into the binding site as modeled by Henderson et al. (1990) and that the retinal 
analogs Khorana Z. and Nakanishi2 i did not fully fit into the ring end of the retinal 
binding site. This qualitative description of the ability of these retinal analogs to occupy 
the retinal binding site correlates with the ability of the BR analog pigments to function 
as a light driven proton pump. The functional characterization of the BR analog pigment 
formed with Khorana l indicates poor proton pumping (in Boehm et al., 1990). This 
retinal labeled amino acids that are the greatest distance from the retinal binding site in 
Henderson's model. The retinal analog NakanishilJ. showed function at about 50%-
100% (see above) of the level of native BR and labeled amino acids in Henderson's 
model well situated to be in contact with the reactive intennediate. The retinal analog 
Nakanishi2 4 showed function at about 1/5 the level of native BR and labeled amino 
acids an intermediate distance from the retinal binding site in the model. Thus, function 
of these retinal analogs as BR analog pigments correlates roughly with the labeling of 
amino acids near the native retinal binding site in the model. Overall these predictions 
show the utility of the model for evaluation of other experimental results and the utility 
of photoaffinity labeling experiments to evaluate the model. 
Predictions were made for the most promising of the retinal analogs in these 
studies. The results from the predictions using TF4N311 show the likely labeling of 
Thr121 and Ser141 if this retinal analog fits well into the retinal binding site as was 
suggested by the -40% efficiency of proton pumping determined during the functional 
characterization of the analog pigment. 
These studies demonstrate the power of molecular modeling for prediction of 
experimental results. These predictions form the basis of the hypothesis that the amino 
acids in these sets would be labeled by a retinal analog bound in the native retinal 
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binding site. More sophisticated applications of molecular modeling are being used to 
aid in rational drug design with BR being used as the basis for modeling members of the 
class of GPCR [Stone, 1992; Hibert et ai., 1991; Pardo et ai., 1992]. 
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Figure 4.1 Photoactivated Intermediates of Retinals l,l,i,ll. 
Each retinal analog is shown as its highly reactive intennediate produced by 
photoactivation. Indicated on the top compound are the centers of rotation for the 3 
different sets of sites of labeling. The sets are based on measurements from 
#1, #2 and #3 to the reactive group (*). These centers of rotation were used for each 
analog. 
Figure 4.2 Outside 
This view, from the cytoplasmic side, of BR's 7 
transmembrane helices from SYBYL depicts in gray and 
full sidechains the amino acids that were chosen as outside 
the barrel of BR and unlikely to be labeled by any 
photoactivatable analog of retinal. These amino acids were 
excluded from the predicted sites of labeling. 
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Figure 4.3 Nakanishil Set #1 
Side view of BR from SYBYL indicates in black the set of 
amino acids predicted to be labeled by J. if rotation is allowed 
of the entire lysine side chain and retinal about the a-carbon of 
Lys 216. 
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Figure 4.4 Nakanishi! Set #2 
Side view of BR from SYBYL indicates in black the set of 
amino acids predicted to be labeled by l if rotation is allowed 
of the retinal analog about the nitrogen of the Schiff base. 
4-16 
Figure 4.5 Nakanishi! Set #3 
Side view of BR from SYBYL indicates in black the set of 
amino acids predicted to be labeled by J. if rotation is allowed 
only of the ring of the retinal analog about carbon 6 as 
numbered in retinal! (fig. 1.1). 
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Thr121// ~ .. 
Gly122 i -{ 
Figure 4.6 Nakansihil's Labeled Sites 
Side view of BR from SYBYL indicates in black the amino 
acids that were labeled by l in the experiments by Ding et al., 
1990. These two amino acids, Thr121 and Gly122, are in all 
three sets of predicted labeling sites for this retinal analog. The 
amino acids in dark gray are the other amino acids in set #3 
from the predictions. 
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Figure 4.7 Khorana's Labeled Sites 
Side view of BR from SYBYL indicates in black 
the amino acids that were labeled by Z. in the 
experiments of Huang et aI., 1982. These two amino 
acids, Ser193 and Glu 194, are NOT in any of the sets 
of predicted labeling sites for this retinal analog. 
The amino acids in dark gray are the amino 
acids in set #3 from the predictions. 
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Figure 4.8 Nakansihi2's Labeled Sites 
Side view of BR from SYBYL indicates in black the 
amino acids that were labeled by ~ in the experiments 
by Boehm et ai., 1990. Of the four labeled amino 
acids (AlaI26, Leu127, Trp137, and Trp138) only 
Trp138 was predicted to be labeled. Trp138 was a 
member of all three sets predicted for this retinal analog. 
The amino acids in dark gray are the amino acids 
in set #3 from the predictions. 
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Figure 4.9 Table of Predicted Sets for Selected Retinal Analogs 
This large table is a summary of the results of the studies described in this chapter. The 
first column shows the complete amino acid sequence of BR. The second column 
shows those amino acids that are included in the structure from Henderson et al. , 1990. 
The third column are those amino acids excluded from the predicted sets because they 
are believed to be oriented towards the outside of BR (see figure 4.2). The fourth 
column then indicates the possibilities for the predicted sets, i.e. those amino acids in 
Henderson's structure that are oriented toward the inside of the barrel of BR. The 
remainder of the table is in sets of three columns indicating the members of the three 
different predicted sets for the indicated retinal analogs. Also the measurements from 
the center of rotation to the reactive moiety are indicated in angstroms near the top of 
each column. 
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Evaluation of Labeling with Radiolabeled Tetrafluoro-4-
azidoretinal, A Photoactivatable Retinal Analog. 
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Introduction. 
The objective of the experiments described in this chapter was to determine if 
and to what extent radiolabeled photoactivatable retinal analogs would crosslink to BR 
as a function of amount of irradiation. The work described in the preceding chapters 
sets the basis for these experiments. Formation and characterization of the analog 
pigments showed the 'biological activity' for the retinal analogs indicating their abilities 
to mimic the characteristics of the retinal based pigment. The model photolysis studies 
gave two viable alternatives for irradiation of the retinal analog pigments. It is shown 
here that the amount of light necessary to activate the model compound does not cause 
significant damage to the protein. The molecular modeling studies predict which sites in 
the protein are likely to be labeled. It is critical to show that the analogs do crosslink: to 
the protein in a light dependent manner. These experiments are modeled after those 
reported in the successful experiments of Huang et al. (1982) and Ding et al. (1990). 
(The determination of amount of crosslinking by Boehm et al. (1990) was not described 
at length.) Critical to the described experiments is the availability of radiolabeled, 
photoactivatable retinal analog. This involves the synthesis from commercially available 
tritiated retinol (C-11 and C-12 are tritiated) or the introduction of a tritium at the C-15 
position by an extra reduction/oxidation cycle using sodium borotritiide as the reducing 
agent [Huang et aI., 1982; Boehm et ai., 1990]. It would be more desirable to 
radiolabel the analog closer to the photoactivatable group to decrease the risk of the 
radiolabel being cleaved from the photoactivated moiety during protein manipulations, 
thus separating the chemically reactive end from the 'reporter', radiolabeled end of the 
retinal analog [Dohlman et aI., 1990; Ding et al., 1990]. In fact, Ding et aI. (1990) 
explicitly stated that the ester linkage between the photoactivatable group and the rest of 
the retinal was cleaved quantitatively in the CNBr cleavage step. Thus, it was critical 
for their experiments that the radiolabel was proximal to the ester linkage. 
The methods used are based on those of Huang et al. (1982) and Ding et al. 
(1990). However, some modifications were made due to the presence of isomeric 
impurity of the radiolabeled version of TF4N3 (lID. Purification of the all-trans isomer 
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was not undertaken because the amount of total radiolabeled TF4N3 synthesized was 
extremely small (-70 Jlg). Since this compound was isomerically impure, it was 
necessary to bind the non-specifically bound retinal analog with fatty acid free BSA. 
Thus, the isomers of TF4N3 that do not fOffil a BR analog pigment (i.e. other than the 
all-trans isomer) were bound to BSA instead of being non-specifically bound to BR. 
The presence of excess BSA also gave an internal control for the ability of TF4N3 to 
crosslink to proteins in a photolysis dependent manner. In other words, the excess BSA 
bound the TF4N3 which did not fOffil a BR analog pigment and acted as a scavenger of 
activated TF4N3 nitrene. 
The methods used here included improvements in technique beyond those used 
in the successful experiments of Huang et ale (1982) and Ding et al. (1990). A 
competitive block with cold ATR was incorporated. Since in these samples the retinal 
binding site was occupied by the native ATR, the radiolabeled TF4N3 could not form a 
BR analog pigment and would be bound to the excess BSA in the photolysis mixture. 
The amount of photolysis was varied from no photolysis to ten times the amount that 
was necessary to completely activate the model compound for TF4N3 as described in 
Chapter 3 using both of the light sources. Once photolysed most of the excess BSA 
was removed by decanting the supernatant after centrifugation. Then, separation of the 
residual BSA from BR and the separation of non-crosslinked retinal analog from BR 
was accomplished with SDS-PAGE. Two identical gels were run simultaneously. One 
of the gels was cut into slices, and each slice was assayed for radioactivity. The other 
gel was stained with Coomassie, photographed, treated with scintillant to prepare for 
fluorography, exposed to X-ray film and analyzed as the fluorograph. 
As described below, these methods were evaluated using reduced tritiated BR 
(RTBR) and non-reduced tritiated BR (Hot BR) as positive and negative controls. 
Reduced tritiated BR was made by the regeneration ofBR with tritiated ATR (-10 
mCi/mmol) and reduction of the Schiff base using the methods of Bayley et ale (1981) 
and Peters et ale (1976). Analysis of the non-reduced fonn showed that the SDS-PAGE 
completely cleaved the Schiff base and separated the retinal from BR. Analysis with 
RTBR as aliquots from different time points in the reduction reaction showed the 
techniques utility in detecting small amounts of radiolabel associated with BR. 
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It should be emphasized that these experiments were limited by the total amount, 
the limited purity, and the relatively low specific activity (-10 mCi/mmol) of the 
radiolabeled TF4N3 retinal analog. However, the studies of Huang et al. (1982) and 
Ding et al. (1990) indicated the possibility of successful determination of percent 
labeling with a single time course of photolysis experiment. Huang et al. (1982) and 
Ding et al. (1990) showed a time of photolysis dependent increase in radioactivity 
associated with BR with a single time course of photolysis study. 
Unfortunately, VBN-II ~ could not be used in similar studies since it was not 
available in radiolabeled form. As described in the next chapter, attempts to detennine 
sites of labeling without radio labeled analogs have been unsuccessful. 
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Materials and Methods. 
A comparison of the methods described here with those of the three reported 
successful photoaffinity labeling experiments of BR is shown in fig. 5.5. The two 
major differences are in the specific activities of the retinal analogs and the presence of 
1 % BSA in the photolysed sample in the studies presented here. The specific activity of 
Khorana 2 was 10 fold higher than that used here. The specific activity of Nakanishi 1 
l was similar to TF4N3 11 (-10 mCi/mmol). Its low specific activity was a major 
reason for the synthesis of Nakanishi2 i at 4800 mCi/mmol, some 480 times higher 
than their previous report of photo affinity labeling of BR. The use of BSA to bind non-
specifically bound isomers of TF4N3 was necessary as described above. However, 
leaving the BSA in the photolysis mixture is more controversiaL The BSA did serve as 
a control for the ability of photoactivated radiolabeled TF4N3 to bind to proteins in 
general. A similar argument is that BSA would scavenge the photoactivated 
intermediates of radiolabeled TF4N3 that were not in the retinal binding site. The use of 
scavengers for photoactivated intennediates was suggested by Bayley (1983). The main 
argument for removing the BSA by decanting the supernatant after centrifugation 
before photolysis is that the large amount of BSA may shield the photoactivatable group 
of TF4N3 from the activating photons. Although possible, this shielding would likely 
be overcome by the large amount of total photolysis described in the experiments below. 
The best method for overcoming the potential troubles caused by the BSA is synthesis 
of isomeric ally pure photoactivatable retinal analogs thus obviating the use of BSA 
altogether. The very difficult synthesis of this retinal analog, which was made even 
more difficult by the addition of the two steps necessary for radiolabeling, made the 
preparation of isomerically pure radiolabeled TF4N3 extremely difficult. Partial 
removal of the BSA by centrifugation before photolysis is a reasonable alternative. 
However, the very limited amount of radiolabeled TF4N3 limited the analysis to the 
experiments presented below. 
Materials. The following materials and suppliers were used in the experiments 
described in this chapter. Tritiated TF4N3 retinal analog was prepared by Bernice Katz 
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at a specific activity of -10 mCi/mmoi. The extinction coefficient was estimated at 50 
000 using that of phenylretinal [Bayley et al., 1981]. Bleached BR with 280/570 ratio 
< 3 when regenerated with ATR was used to fonn the analog pigments. ATR (Sigma) 
freshly dissolved in ethanol and its concentration checked was used to bind to the retinal 
binding site in the blocking experiments. Tritiated ATR (-10 mCi/mmol) was used in 
the negative and positive control samples. The sample cell discussed in Chapter 3 with 
a 1 mm path length was used for the photolysis. The two light sources (Flash 
Apparatus or RPR-100) were used to irradiate the samples. One percent fatty acid free 
BSA (Sigma) in water was used to non-specifically bind excess retinal and retinal 
analogs. The scintillation cocktail used was Aquasol-2 (DuPont) and the counts 
determined in a scintillation counter (Beckman lOOSe). SDS-PAGE was perfonned 
using a Bio-Rad mini-gel apparatus and 12.5% precast minigels (BioRad) according to 
the manufacturer's suggestions. Gel slices were solubilized with Solvable (DuPont). 
KCI (1 M, Sigma) was used to visualize the protein bands on the gel that was sliced and 
counted [Bergman and Jornvall, 1987]. Before fluorography the gels were treated with 
En3Hance (DuPont). The treated gels were exposed to X-ray film (X-Omat, Kodak) or 
Hyperfilm (Amersham). 
Metlwds. Pigment Formation. An analog pigment was formed as described in 
Chapter 2 with tritiated TF4N3 retinal. Additional tritiated TF4N3 was added until there 
was spectral evidence for an excess of TF4N3 over BR. This excess was shown by an 
increase in the absorbance due to the retinal analog free in solution (-390 nm) with no 
further increase in the absorbance from the analog pigment (-520 nm). An equivalent 
amount of 'blocked' pigment was fonned by a treatment with a 2 fold excess of non-
radiolabeled ATR (by absorbance over the previously determined amount of ATR 
necessary to regenerate BR from this amount of bleached BR) before addition of the 
radiolabeled TF4N3 retinal. These pigments were allowed to incubate at 4 C for 1 hour. 
Then, the samples were diluted with 1 % BSA (10 mg/ml) to 4 ml. The final [BR] was 
0.1 mg/rnl, -4 JlM. The pigment/BSA mixture was then placed in the cooled sample 
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cell. 
Photolysis. Three separate experiments were performed. The fIrst sample was 
photolysed from 0-30 min in the RPR at 350 nm at 4 C. A second sample was 
photolysed from 0-240 min in the RPR at 350 nm at 4 C. A third sample was 
photolysed using the flash apparatus from 0-100 flashes at 10 kV at 4 C. One m1 
aliquots were removed at appropriate intervals. The irradiation was repeated with the 
'blocked' pigment (that had been pretreated with excess ATR) for the fIrst and third 
samples. Due to a lack of tritiated TF4N3, this control was not performed for the longer 
irradiation at 350 nm. The samples were then centrifuged (20 OOOg, 30 min) to pellet 
the pigment (most of the BSA remains in the supernatant). The supernatant was 
decanted to a scintillation vial and counted in 10 mL of Aquasol-2. Some BSA, as will 
be evident below, remained with the BR pellet thus allowing evaluation, by SDS-PAGE, 
of any radiolabel covalently linked to the BSA concurrently with the analysis of BR. 
SDS-PAGE. The pellets were resuspended in standard SDS-PAGE sample buffer. 
They were sonicated for 15 minutes in an ultrasonic water bath and then heated to 70 C 
for 2 minutes. Sonication and heat are necessary to solubilize the BR in the sample 
buffer. The complete solubilization allows the BR to run as a monomer by SDS-PAGE. 
It was necessary to have BR run as a single band to optimize the chances for detecting 
small amounts of radioactivity associated with BR. If the BR was not sonicated and 
heated, it ran as monomers, dimers and trimers thus spreading any potential counts 
associated with BR over three separate bands. It also should be noted that Huang et ale 
(1982) heated their BR samples to 100 C in one of their assays of crosslinking. The 
samples were then loaded (-10 J,lg on each lane, -2000 cpm) on two identical minigels. 
The same amount of sample that was loaded was added directly to a scintillation vial. 
Aquasol-2 (10 mL) was added and the samples counted in the liquid scintillation 
counter. This value was taken as the total amount loaded on each gel and used as the 
denominator in calculation of percent radiolabel remaining associated with BR. The gels 
were run at 200 V for -40 min. In two cases the dye front was not run off of the 
bottom of the gel and the high counts associated with the dye front (fig. 5.1b and fig. 
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5.2b) indicate that the highly lipophilic retinals run with the SDS at the dye front. This 
should not be taken as a labeling of the lipids from the BR samples as one would not 
expect SDS-PAGE to separate retinals alone from photoactivated retinals covalently 
linked to lipids. Also, these high counts in the dye front were also seen in the negative 
and positive controls which did not contain photoactivatable compounds. One of the 
twin gels was fixed, stained in Coomassie and destained. The other gel was stained 
with 1 M KCI [Bergman and Jomvall, 1987] to visualize the protein bands. As 
experience was gained fewer and fewer slices were necessary for successful isolation of 
the BSA and BR containing gel pieces. The gel was sliced by lane and by band, and the 
pieces were removed to vials. The proteins were solubilized from the gel slices using 
Solvable according to manufacturer's directions by addition of 500 JlI of Solvable to the 
gel slices and heating to 50 C for three hours. To these solubilized slices, Aquasol-2 
(10 mL) was added and the samples were counted in the scintillation counter. The 
stained gel was treated with En3Hance (a scintillant, according to the manufacturer's 
suggestions) and exposed to X-ray film (X-Omat or Hyperfilm) for 1 week at 193 K. 
The impregnation of the gel with scintillant increases the efficiency of conversion of the 
decay of the tritium to exposure of the X-ray film. The counts were analyzed for an 
irradiation dependent increase in counts associated with the BR band [Ding et al., 1990; 
Huang et al., 1982]. The X-ray film was developed and analyzed similarly. 
Later, non-radiolabeled TF4N3 retinal was analyzed similarly to the model studies 
of TF4ABA in organic solvents. The retinal analog was dissolved in cyclohexane or 
dioxane and photolysed in the RPR at 350 nm. Aliquots were taken at different time 
points and analyzed by GC-MS as described for the retinals in Chapter 2 or by FAB-MS 
by Kelly Thornburg or by direct probe electron impact ionization with the help of Ken 
Patrick. The spectra were analyzed for a photolysis dependent change in mass, 
especially for the addition of the organic solvent to the photoactivated intermediate. The 
masses of interest were 351 m/z (TF4N3, azide), 323 (TF4N3, nitrene), 325 (TF4N3, 
amine, NH2) or 323+mass of solvent (TF4N3 nitrene + solvent). 
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Results and Discussion. 
Positive Control (fig. 5.1). These methods were evaluated using positive and 
negative control samples made from bleached BR that was regenerated with tritiated 
ATR. The negative control sample was, simply, this regenerated pigment in which the 
retinal was bonded through the nonnal protonated Schiff base to Lys216. The positive 
control sample was this tritiated BR that had had the Schiff base reduced to form a non-
hydrolyzable bond [Bayley et aI., 1981] and was subsequently referred to as RTBR. 
This linkage is stable to all of the protein manipulations subsequently used. The results 
of the positive control SDS-PAGE and slicing and counting are shown in fig. 5.1. The 
percent reduction of the Schiff base at the 90 min timepoint was estimated at 12% (see 
fig. 5.1 lane 8, fig. 5.2 lane 10). These studies also showed that the nonnal Schiff base 
was completely cleaved under these conditions and that the tritiated retinal was separated 
from the BR (see Lane 1, fig. 5.3). It is interesting to note that sodium borohydride 
treatment of BR cleaves the protein into two pieces, one of which contains Lys216 and 
hence the radiolabeled retinal attached by the reduced Schiff base [Ding et aI., 1990]. 
This cleavage accounted for the two small bands found on gels below the BR band in 
the RTBR lanes and for the additional faint spot in the fluorographs corresponding to the 
smaller band. The 90 min RTBR was used in subsequent gels as a positive control and 
was labeled RTBR. Since the amount of radiolabel associated with BR was easily 
detected even after only 5 minutes of reduction and since the specific activity of the ATR 
used in these control studies is similar to that of the TF4N3 used in the photolysis 
studies, the limit of detection was estimated at <5%. This detection limit should be 
sufficient to detect labeling in studies of photoaffinity labeling of BR. Using similar 
techniques, Huang et al. (1982) reported 20% labeling; Ding et ale (1990) estimated 25-
30% labeling; Boehm et ale (1990) reported 15%. 
The tritiated TF4N3 was made by Dr. Bernice Katz at a specific activity of -10 
mCi/mmol. Because this compound was isomeric ally impure, it was important to bind 
the isomers of TF4N3 that would only non-specifically associate with BR (i.e. any 
isomer that is not all-trans) with BSA and control for non-specific labeling by including 
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blocking the retinal binding site with non-radiolabeled ATR in one set of samples. It 
was hoped that a time of photolysis dependent increase in the amount of radioactivity 
associated with BR would be observed [Huang et al., 1982; Ding et al., 1990]. Both 
light sources were used in attempts to photoactivate the tritiated TF4N3 bound to BR. 
Flash Photolysis (fig. 5.2). The results of the flash photolysis are shown in fig 5.2. 
This figure shows the Coomassie stained SDS-PAGE gel of the separation of the 
residual BSA from BR and the radioactivity counts associated with the different samples 
and bands (fig. 5.2b). The blocking with ATR procedure was efficient as shown by the 
fact that the radioactivity associated with the BR pellet was much lower in the blocked 
samples than in the non-blocked samples (335+49 cpm vs. 1609±160 cpm, 
respectively). The percent of radioactivity associated with BR in the blocked samples 
was not calculated because the total counts loaded were so low. The positive control 
shows the detection of the radioactivity associated with BR in lane 10. Lanes 2-5 show 
a slight increase in percent radioactivity associated with BR with increasing number of 
flashes. This change was from 0.7% to 1.7% - a possible labeling of only 1 %. Lane 5 
and Lane 9 show multiple bands due to protein damage from the high number of flashes 
(100 flashes). This protein degradation was not surprising considering the high amount 
of UV light emitted by the flash lamp. It should be emphasized that the sample was kept 
at 4 C throughout the photolysis which suggests that this protein degradation was likely 
light induced rather than heat induced. 
Photolysis at 350 nm (figs. 5.3 and 5.4). The results of the 350 nm photolysis are 
shown in fig 5.3 (0-30 min) and fig. 5.4 (0-240 min). These figures show the 
Coomassie stained SDS-PAGE gel of the separation of the residual BSA from BR and 
the radioactivity counts associated with the different samples and bands (figs. 5.3b, 
5.4b). The blocking with ATR procedure was efficient as shown at the shorter 
irradiation times shown in fig. 5.3 by the fact that the radioactivity associated with the 
BR pellet was much lower in the blocked samples than in the non-blocked samples 
(352±27 cpm vs. 1591 + 179 cpm, respectively). The percent of radioactivity associated 
with BR in the blocked samples was not calculated because the total counts loaded were 
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so low. The positive control with RTBR is shown in lane 1 of fig. 5.4 with 9.8% of the 
loaded radioactivity associated with BR. The amount of radioactivity associated with 
BR in the non-blocked photolysed samples ranges from 0% to 1.3%. This indicates 
that very little if any TF4N3 crosslinked to BR even after this extended photolysis. 
These studies indicate that little or no significant labeling of BR occurred with 
radiolabeled TF4N3 under the conditions described when the estimate of limit of 
detection of a significant increase over time of photolysis was set at <5%. This limit of 
detection is relatively high due to the relatively low specific activity of the radiolabeled 
TF4N3. The results presented were corroborated by fluorography performed on 
identical gels. The fluorographs showed only the bands from the positive control lanes 
and no other bands. It should be emphasized that despite the low specific activity, these 
experiments would have shown labeling of the protein if the efficiency of labeling had 
been similar to previously published reports of photoaffinity labeling of BR. Using 
similar techniques, Huang et ale (1982) reported 20% labeling; Ding et al. (1990) 
estimated 25-30% labeling; Boehm et ale (1990) reported 15%. Both light sources were 
used and at a wide range of total photolysis to maximize chances of success. Significant 
protein damage occurred only after more than 50 flashes (5X that required to completely 
activate the model compound, fig. 5.2, lane 5+9). 
There are several possible reasons for this lack of success in labeling BR with this 
photoactivatable retinal analog. 
The excess BSA in the photolysis samples shielded the TF4N3 from the necessary 
photonsfor activation of the azide to the nitrene. As discussed above in the methods 
section, the use of BSA was necessary to bind the isomeric impurities in the 
radiolabeled TF4N3. Photolysing the samples before centrifugation to remove most of 
the BSA may have allowed the high concentration of BSA to absorb much of the light 
during photolysis. However, the extended photolysis times and the short path length in 
the sample cell (1 mm) should overcome these possible shielding effects. The best 
solution to this possible difficulty with BSA would be synthesis of pure radiolabeled all-
trans TF4N3. The other reasonable alternative of removing most of the BSA by 
centrifugation before photolysis was not performed due to the lack of radiolabeled 
TF4N3. 
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The nitrene resulting from the photolysis ofTF4N3 was not sufficiently reactive to 
efficiently bind to BR. This possibility depends on the differences in reactivity between 
the nitrene resulting from photolysis of the model compound TF4ABA and that of the 
full retinal (TF4N3). As described in Chapter 3, the TF4ABA, the benzaldehyde, 
efficiently crosslinked to the inert organic solvent cyclohexane in a photolysis dependent 
manner. Recently, similar model photolysis studies with TF4N3 in cyclohexane and 
dioxane have been performed to investigate the possible lack of reactivity of the nitrene 
derived from photolysis ofTF4N3. These studies have shown only the amine (NH2' 
mass 325) in the photolysed samples. These results indicate that, unlike the 
benzaldehyde, the full retinal analog does not, when photolysed, react with the solvent 
through C-H insertion. The formation of the amine is likely due to the triplet derived 
abstraction of hydrogens from the solvent. This reaction requires much less reactivity 
and is one of the products of reaction of many of the highly fluorinated aryl azides that 
have been synthesized as potential photoactivatable groups [Leyva et al., 1986a,b, 
1989; Keana et al., 1988, 1990; Cai et al., 1992, Soundarajan et al., 1990]. In fact the 
high yield of the C-H insertion derived product with the benzaldehyde (TF4ABA) was 
remarkable. This success with TF4ABA indicating the reactivity of polyfluorinated aryl 
azides encouraged the many attempts to synthesize the full retinal analog containing this 
photoactivatable group. 
There is some theoretical and experimental evidence that suggests that the chemistry 
of the para position of the ring of the benzaldehyde may be considerably different from 
that of the retinal analog in which the aldehyde is separated from the aromatic ring by an 
extended conjugated double bond system. Assuming that the groups closest to the ring 
have the most effect, it should be noted that the aldehyde and the conjugated system 
have different electron affmities. The aldehyde is more electron withdrawing than the 
conjugated double bond system [Hansch etal., 1973]. The difference in chemistries of 
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the para position of the ring of pentafluorobenzaldehyde and of pentafluororetinal was 
demonstrated by the relative ease of substitution of the para fluorine with sodium azide. 
The substitution reaction at the benzaldehyde level is quantitative (see appendix 1) and 
was successfully completed by even the most inexperienced organic chemist. The para 
fluorine could not be substituted with azide after the retinal sidechain had been added 
[Bernice Katz, personal communication]. Fujjii et al. (1989) had difficulty substituting 
the para fluorine of pentafluorotoluene, but no trouble with the benzaldehyde. This 
difference in chemistries would also affect the reactivity of the resulting nitrene. The 
photolysis conditions were certainly adequate to activate the model benzaldehyde to a 
highly reactive nitrene, but may not have activated the full retinal analog to a highly 
reactive intermediate. It should be noted that the reports suggesting the use of 
polyfluorinated aryl azides as photoactivatable groups have studied highly fluorinated 
aryl azides that have electron withdrawing groups para to the azide [Leyva et al., 
1986a,b, 1989; Keana et al., 1988, 1990; Cai et al., 1992, Soundarajan et al., 1990]. 
It has also been suggested that the extended conjugation of the retinal sidechain 
influences the reactivity of the nitrene [MS Platz, personal communication]. The nitrene 
in TF4N3 is in conjugation with the extended 1t system of electrons formed by the ring 
and the sidechain. This conjugation allows delocalization of the electrons of the 
nitrene. This delocalization is further supported by the resonance structures that can be 
drawn for the nitrene in which the electrons can be moved throughout the conjugation. 
Thus, the nitrene from the full retinal analog, in comparison to that of the benzaldehyde, 
may be considerably less reactive. This difference in reactivities is supported by the 
formation of the C-H insertion product upon photolysis of the benzaldehyde in 
cyclohexane and the formation of the amine on photolysis of the full retinal analog in 
cyclohexane. It should be noted that the photoactivated intermediates of the successful 
photoaffinity labeling experiments of BR using Khorana 1, Nakanishi1 l, and 
Nakanishi2 4 were highly reactive carbenes (instead of the less reactive nitrenes) that 
were NOT in conjugation with the double bond system of the retinal sidechain. 
If these differences are the reason for lack of labeling, the problem is inherent in the 
structure of the retinal analog. To overcome this possibility, other photoactivatable 
retinal analogs must be developed. 
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TF4N3 is not bound in the native retinal binding site. The BR analog pigment 
fonned with TF4N3 showed a reasonable opsin shift and partial functioning which 
strongly supports its placement in the native retinal binding pocket. This pocket has the 
ring end of retinal buried in the TMH. However, the aromatic analog, Khorana (1Jl) 
labeled Ser193 and Glu194 which are modeled to be extramembranous. Thus it is 
possible that, despite the opsin shift, and the partial functioning of the TF4N3 BR 
analog pigment, the ring end of 1F4N3 actually labeled the water or lipids surrounding 
BR in the purple membrane. Again, this possibility is inherent to the structure of the 
retinal analog. The solution is design and synthesis of superior retinal analogs. 
The analog itselfwas unstable to the aqueous environment usedfor pigment 
formation and never made it into the protein intact. With the general difficulty in 
characterizing this retinal analog, it would be extremely difficult to perfonn experiments 
to test this possibility. Again, the solution is different retinal analogs. 
The crosslink/ormed was unstable to the analysis conditions. This is an 
unfortunate possibility since the conditions of this assay for crosslinking are very mild 
in comparison to those used in the further work-up of the protein for analysis of sites of 
labeling. 
The radiolabel was cleaved/rom the plwtoactivatable group. Again this possibility 
is unfortunate considering the relatively mild conditions of the crosslinking assay. It is 
well known that retinal is a labile compound [Bownds, 1967] and that labeling 
experiments have been ruined by such cleaving of the reporter radio label [Dohlman et 
al., 1988]. The solution to this problem is the incorporation of the radiolabel into the 
retinal analog on an atom close to the carbene or nitrene [Ding et ai., 1990]. 
In summary, the fonnation of these crosslinks (labeling) is the point of these 
experiments. This lack of labeling makes the kinetic spectroscopy studies of the 
irradiated and non-irradiated fonn of the TF4N3 analog pigment simple to interpret, 
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since no difference was noted. In the final chapter, several suggestions are made to 
improve the likelihood of success of these experiments. These suggestions do not 
involve modification of the methods of assaying for crosslinking or of the photolysis 
conditions. These suggestions are for the synthesis of new retinal analogs that 






1 2 3 4 5 6 7 8 9 10 
Sample cpm BRLcpm loaded (%) 
Lane 1 Blank 
Lane 2 RTBR at5 min 7.2 (67/927) 
Lane 3 Blank 
Lane 4 RTBR at 15 min 8.7 (78/900) 
Lane 5 Cold Reduced BR 
Lane 6 RTBR at 30 min 13.5 (77/571) 
Lane 7 MW standards 
Lane 8 RTBR at 90 min 11.5 (240/2080) 
Lane 9 RTBR atO min 0.2 (2/1046) 
Lane 10 Cold PM 
Figure 5.1 SDS-PAGE of Reduced Tritiated BR 
Top panel: Photograph of coomassie stained gel. Each lane was loaded 
with -1 0 ~g of the sample indicated in the key. The gel was run, sliced 
and counted as described in materials and methods. 
Bottom panel: The results are expressed as (%) radioactivity associated with 
BR/ Total radioactivity loaded in that lane with the cpm values 




Lanel Lane 2 Lane 3 Lane 4 LaneS Lane 6 Lane 7 Lane 8 Lane 9 Lane 10 
Sample DR 3HDR 3HDR MW 3HBR DR 3HBR Blank 3HBR Blank 
Reduction o min 90 miD. 30 min 90 min 15 min 5 min 
Loaded 25 1071 2105 2S 596 26 925 24 952 
Gel slice 1 29 28 29 26 33 TI 31 25 32 
Gel Slice 2 28 28 29 23 28 26 25 27 27 
BSA V 31 33 28 28 29 32 26 25 
BSA 28 Z7 31 32 24 26 28 28 23 
Gel slice 5 30 26 33 26 2S 22 28 26 29 
Gel slice 6 27 29 29 26 29 25 27 28 25 
BR 25 28 44 43 63 24- 40 40 30 
BR 26 26 130 33 43 29 58 31 62 
BR 28 Z1 145 29 50 30 59 33 54 
Dye Front 29 214 236 71 80 30 110 71 167 
Background Loaded = 25 
Background BR = 78 
BR-Background/Loaded-Background 
211046 240IlOSO 77/571 78/900 67/927 
Figure S.tb Raw cpm Data from SDS-PAGE of Reduced Tritiated BR 
Gel was sliced, solubilized, added to scintillation cocktail and counted. 
Lane 
1 2 3 4 5 6 7 8 9 10 
Sample cpm BRLc12m loaded (%) 
Lane 1 Cold BR 
Lane 2 o Flash 0.7 (12/1721) 
Lane 3 1 Flash 1.1 (16/1492) 
Lane 4 10 Flash 1.2 (18/1418) 
Lane 5 100 Flash 1.7 (29/1723) 
Lane 6 o Flash - Blocked (8/254) 
Lane 7 1 Flash - Blocked (7/306) 
Lane 8 10 Flash - Blocked (5/298) 
Lane 9 100 Flash - Blocked (12/373) 
Lane 10 RTBR at 90 min 14.2 (103/725) 
Figure 5.2 SDS-PAGE of Flash Photolysis with Radiolabeled TF4N3 
Top panel: Photograph of coomas ie stained gel. Each lane was loaded 
with,..., 10 Jlg of the sample indicated in the key. The gel was run, sliced 
and counted as described in materials and methods. 
Bottom panel: The results are expressed as (%) radioactivity associated with 
BR/ Total radioactivity loaded in that lane with the cpm values 





Lane 1 Lane 2 Lane 3 Lane 4 LaneS Lane 6 Lane 7 LaneS Lane 9 Lane 10 
Pretrealmenl None None None None None Excess A TRExcess A 1RExcess A TRExcess A 1R None 
Sample BR o Flashes lRuh 10 Flashes 100 Fluhes 0 Rubes 1 Flash 10 Flashes 100 Flashes RTBR 
Loaded 1748 1492 1445 1750 281 333 325 400 752 
Comb 43 41 42 34 31 30 33 33 28 
BSA 28 53 60 SO 46 37 36 28 34 TI 
BSA 30 36 37 42 39 29 23 24 33 29 
BR 26 33 35 31 34 24 28 26 TI 32 
BR 25 30 32 38 46 35 30 30 36 122 
Dye Front 28 310 416 396 358 110 79 85 106 115 
Supernatant 5896 6147 6214 6051 15520 15726 15233 14418 
Background Loaded = T1 
Background BR = 51 
BR·Background/Loaded-Background 
12/1721 16/1492 18/1418 29/1723 8/254 7/306 5(298 12/373 103n25 
Figure S.2b Raw cpm Data from SDS-PAGE of Flash Photolysis 
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Figure 5.3 SDS-PAGE of 350 nm Photolysis with Radiolabeled TF4N3 
Top panel: Photograph of coomassie stained gel. Each lane was loaded 
with -10 J.lg of the sample indicated in the key. The gel was run, sliced 
and counted as described in materials and methods. 
Bottom panel: The results are expressed as (%) radioactivity associated with 
BR/ Total radioactivity loaded in that lane with the cpm values 





Lane 1 Lane 2 Lane 3 Lane 4 Lane 5 Lane 6 Lane 7 Lane 8 Lane 9 Lane 10 
Pretreatment None None Excess A 1RExcess A TRExcess A TR None None None None None 
Sample HOlBR BR o min 10 min 30 min o min 2 min 5 min 10 min 30 min 
Loaded 882 29 324 379 353 1545 1556 1845 1743 1419 
Gel slice 1 26 V 21 81 90 33 104 29 29 34 
BSA 26 24 20 26 32 29 29 33 46 33 
BSA 28 31 29 48 33 22 29 23 34 21 
Gel slice 4 25 21 21 64 31 26 23 29 25 25 
Gel slice 5 37 34 22 39 82 29 20 26 52 23 
Gel slice 6 34 25 23 33 39 24 23 29 29 39 
BR 24 39 25 36 1:1 30 31 24 36 28 
BR 33 28 37 Z1 31 30 1:1 26 23 33 
GeIBOUDm 24 1:1 32 22 50 68 26 32 36 35 
Supernatant 2424 26 11750 11589 12198 5142 5346 3426 4140 5161 
Background Loaded = 29 
Background BR = 67 
BR· Background/Loaded~ Background 
7/853 12/295 13{350 8/324 10/1516 8/15Z1 0/1816 9/1714 11/1390 
Figure S.3b Raw cpm Data from SDS-PAGE of 350 om Photolysis 
Gel was sliced, solubilized, added to scintillation cocktail and counted. 
Lane 
1 2 3 4 5 6 7 8 9 10 
Sample cpm BRLcpm loaded (%) 
Lane 1 RTBR at 90 min 9.8 (147/1494) 
Lane 2 Blank 
Lane 3 OminRPR 0.0 (0/2379) 
Lane 4 Blank 
Lane 5 60 min RPR 1.3 (22/1627) 
Lane 6 Blank 
Lane 7 120 min RPR 0.7 (10/1330) 
Lane 8 Blank 
Lane 9 240 min RPR 0.2 (1/762) 
Lane 10 Blank 
Figure 5.4 SDS-PAGE of 350 nm Photolysis with Radiolabeled TF4N3 
Top panel: Photograph of coomassie stained gel. Each lane was loaded 
with""' 1 0 J.lg of the sample indicated in the key. The gel was run, sliced 
and counted as described in materials and methods. 
Bottom panel: The results are expressed as (%) radioactivity associated with 
BR/ Total radioactivity loaded in that lane with the cpm values 





Lane 1 Lane 2 Lane 3 Lane 4 Lane 5 Lane 6 Lane 7 Lane 8 Lane 9 Lane 10 
Sample RTBR (90) Blank 0 min Blank 60 min Blank 120 min Blank 240 min Blank 
Loaded 1555 2440 1688 1391 
BSA 35 79 63 5S 
BR 208 61 83 71 
Supernatant 11389 12521 8308 
Background Loaded = 61 
Background BR = 61 
BR-Background/Loaded-Background 
147/1494 2/.2379 22/1627 10/1330 
Figure S.4b Raw cpm Data from SDS-PAGE of 350 nm Photolysis 










Retinal Analog Extinction Coefficient Specific Activity \bsorbance Maximum Retinal/Pigmen 
TF4N3 (11) .... 50000 .... 10 mCi/mmol 390 nm (EtOH)/517 nm 
Khorana (2) -50000 120 mCi/mmol 394 nm (MeOH)/470 nm 
Nakanishil (3) 49000 -10 mCi/mmol 360 nm (hexane)/535 nm 











Proton Pumping Efficien~ Photolysis Conditions 
40% 4 C, 0.1 mglml BR, 10 mg/ml BSA, water 
? ('nonfunctional tf Boehm et al., 1990) 1T, 0.4-1.4 mg/ml BR, water 
50% (Sen et al., 1982), 100% (Ding et al., 1990) 4 C, ?[BR), water 
20% 4 C, 0.39 mg/ml BR, water 
Assay of Crosslinking 
10 ug, SOS·,PAGE slice and count, 70 C, 2 min 
4 ug, SOS-PAGE slice and count & Ethanol Precip. 100 C, 5min 







Figure 50S Comparison ofPhotoaft1nity Labeling Experiments ofBR 
The extinction coefficients of 11 and 2 were estimated from that of phenyl retinal (Bayley et aI., 1981). 
Irradiation 
350 nm (0-240 min), Hash (0-100) 
365 nm, 10 min 
254 nm, 10 min 
254 nm, 2 min 
Amino A cids Labeled 
SerI93, Glul94 
Thr121 , Gly122 
Alal26, Leu127, Trp137, Trp138 
Huang et aI. did not report the pr(:lton pumping efficiency of the BR analog pigment of 2. However, Boehm et al. described it as nonfunctional. 
Oata derived from Huang et aI, 1982; Ding et ai., 1990; Sen et aI., 1982; Ok et al., 1988; Boehm et aI., 1990. 
Chapter 6 




The objective of the studies presented in this chapter is to evaluate the use of mass 
spectrometry and tandem mass spectrometry to detect and identify sites of photo affinity 
labeling of bacteriorhodopsin. Mass spectrometry and tandem mass spectrometry 
(MS/MS) offer potential advantages over the classical Edman methods [Biemann and 
Martin, 1987]. The use of MS and MS/MS to identify modified proteins is well 
established [Biemann and ScobIe, 1987; Biemann, 1992]. The recent addition to 
MUSe of state of the art facilities for these techniques encouraged sophisticated 
application of MS to protein structure experiments on BR. MS/MS can identify amino 
acid modifications sequence specifically [Kaur et al., 1989; Chen et a/., 1989]. (In 
order to gain experience in the mass spectrometric analysis of peptides and proteins 
before the installation of the new tandem mass spectrometer at MUSe, preliminary 
studies were perfonned on shark immunoglobulin light chains at the Massachusetts 
Institute of Technology. The results of these studies are presented in appendix 2.) 
The fIrst step in the mass spectrometric analysis of BR is cleavage of the protein into 
smaller peptides. BR, however, is resistant to most cleavage methods when it is in the 
fann of purple membrane where it is still embedded in a lipid bilayer. Delipidation of 
the protein is necessary before cleavage. Once delipidated, BR can be dissolved in 70% 
fonnic acid and cleaved with CNBr. The mixture of the resulting ten peptides is 
amenable to tryptic cleavage in a nonna1 tryptic buffer. Before the fIrst chemical 
cleavage, delipidated BR is not soluble in the buffers most often used for tryptic 
digestion. After tryptic digestion the final mixture of peptides is ready for HPLC 
fractionation and then for mass spectrometric analysis. The samples from the analog 
pigment made with VBN-II (2) that had been photolysed were also subjected to mass 
spectrometric study and the results were analyzed for mass shifts of the predicted 
peptides consistent with the mass of this retinal analog. 
Mass spectrometric analysis of BR was used initially to confmn the sequence of the 
protein. This work was performed before the introduction of fast atom bombardment as 
an ionization technique. The methods relied on derivitization of the peptides for gas 
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chromatographic mass spectrometric analysis. These methods were particularly useful 
for identification of the pyroglutamic acid as the N-tenninal amino acid in BR [Khorana 
etal., 1979; Gerber and Khorana, 1982]. After the introduction of fast atom 
bombardment ionization, Khorana's and Biemann's lab collaborated again on the use of 
mass spectrometry to confrrm the sequence of BR, but this time on mutants of the 
protein produced by molecular biological techniques. Allmaier et al. (1986) and Martin 
(personal communication) showed the mass spectra of nine of the ten peptides derived 
from the CNBr cleavage. 
The mass spectral studies presented in this chapter were perfonned as initial studies 
of BR on the newly installed JEOL HX110/HX110 mass spectrometer at MUSC. 
These mass spectrometric studies were perfonned only late in the overall studies 
presented here and were not emphasized since detection of a labeled peptide by other 
means was deemed necessary for the successful use of MS for identifying the site(s) of 
labeling. 
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Materials and Methods. 
Materials. The following materials and instruments were used in these analyses. 
Sephadex LH-20 (Pharmacia) was used to delipidate BR. CNBr, NBA, glycerol, and 
thioglycerol were obtained from Aldrich. Ethanol was used as an HPLC solvent (UV-
grade, Pierce). Formic Acid was used to dissolve BR (Sigma). Trifluoroacetic acid 
(Sequencing grade, Pierce) was used in the HPLC solvents. Trypsin was obtained 
from Boehringer-Manheim. The gradient HPLC system consisted of two Waters 510 
HPLC pumps, a Waters gradient controller, a Waters 994 Photodiode array detector, a 
Waters 441 fixed wavelength detector (214 nm), a Vydac (Hesperia, CA) C4 and C18 
reversed-phase HPLC column, and a Waters UK6 injector. A Speed-Vac Concentrator 
was used to remove solvents. A JEOL HXI10/110 High Performance/High Mass 
Tandem Mass Spectrometer (JEOL, Japan) was used for mass spectrometric analysis 
and a computer program that runs on Macintosh computers, MacProMass [Lee and 
Vemuri, 1990] was used to aid in analysis of the data. 
Methods. BR. Delipidation. The lyophilized pigment was resuspended in a small 
amount of 88% fonnic acid and then diluted to 70:30 ethanol:88% fonnic acid. The 
sample was then loaded on a pre-equilibrated Sephadex LH-20 column (50x2cm) and 
eluted with 70:30 ethanol: 88% formic acid. The fractions were analyzed by UV-vis 
spectrophotometry and the protein containing samples (absorbance at 280 nrn) were 
pooled and the solvent evaporated in a Speed-Vac Concentrator [Gerber et aI., 1979]. 
CNBr Cleavage. The delipidated protein was dissolved in a small amount of 88% 
fonnie aeid and sonicated until in solution. This sonication also wanned the sample to 
aid in solubilization. Typically about 5 mg of protein was dissolved in -1 mL of 88% 
fonnic acid. Once solubilized, the solution was diluted to 70% fonnic acid. No 
tryptamine was added since the tryptamine was shown to discolor the solution and cause 
confusion when analyzed using photodiode array detection. A 500 fold molar excess of 
CNBr over the number of methionines was added as a solution in 70% fonnic acid. 
The reaction solution was purged with nitrogen and wrapped in foil. The CNBr must 
be fresh. The sample was then stirred for 24 hours at room temperature then diluted 
two fold with water and lyophilized twice to remove the excess CNBr. 
6-5 
Cleavage with CNBr and Trypsin. Although the CNBr digestion goes to completion 
the HPLC fractionation of some of these very hydrophobic peptides was difficult; 
therefore, the tryptic digestion was carried out after the CNBr procedure without 
intermediate HPLC separation. The dried CNBr derived peptides were resuspended in 
1 % SDS with heat and sonication. The solution was diluted 1:13 with 100 mM 
ammonium carbonate buffer. One percent by weight of trypsin was added in 0.01 % 
TFA. The reaction mixture was incubated at 37 C for 5 hours and then lyophilized. The 
method for use of trypsin in the presence of small amounts of SDS was that of 
Bosserhoff et ale (1989). 
Fractionation by HPLC. The separations were performed on a Waters gradient 
system using a Vydac C4 reversed-phase HPLC column with a small guard column 
containing the same solid phase. The solvents were A: water with .1 % TFA B: ethanol 
.07% TFA. The gradient used was initial 100% A, 0-5 minutes 25% B, 5-60 minutes 
25-100% B, 60-70 minutes 100% B, 70-80 minutes 100% B - 100% A. Flow rate was 
.75 mL per minutes with detection at 214 nm and spectra taken from 200-500 run by the 
994 detector. 
Mass Spectrometry To the fractions collected from the HPLC approximately IJ..LI of 
glycerol was added, the samples vortexed and frozen with liquid nitrogen. The samples 
were placed in a Speed-Vac Concentrator and excess solvent removed. The freezing and 
use of glycerol decreased the sample loss to the walls of the tubes. Once concentrated, a 
small amount (1-5 JlI) of 5-10% of acetic acid was added to each tube and the sample 
vortexed to mix. 
The samples were analyzed with a JEOL HX110/HX110 Tandem Mass 
Spectrometer consisting of two double focusing mass spectrometers of EBEB geometry 
with a mass range of 14000 daltons. Molecular weight detenninations were done in 
MS-1 at resolution 1500. The samples were applied to the probe tip and ionized by 
bombardment with 18 kV cesium ions. Single stage analysis was perfonned with an 
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accelerating voltage of 10 kY. If no sample related ions were observed a small amount 
of p-nitrobenzyl alcohol (NBA) was added to the sample surface and the analysis 
repeated. 
Tandem Mass Spectrometry. Peptides of interest that were in the proper mass range 
were analyzed by MS/MS to detennine their primary sequence and any modifications 
that may indicate labeling [Biemann and ScobIe, 1987]. The MS/MS experiments were 
perfonned with the collision cell operated at 3 kV fuled with helium sufficient to 
attenuate the ion current of the 12C monoisotopic peak by 70%. Once the tandem mass 
spectra were recorded they were interpreted manually with the aid of the known 
sequence ofBR as manipulated by MacProMass [Lee and Vemuri, 1990]. 
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Results and Discussion. 
The delipidation, cleavage, and HPLC fractionation of the resulting peptides showed 
similar results to those previously published [Gerber et al., 1979]. The delipidation 
column completely separated the lipid-like retinal which was yellow from the protein 
which absorbed at 280 nm. CNBr and tryptic cleavage yielded HPLC profiles that 
showed many peptide peaks consistent with efficient cleavage. All fractions from 
several HPLC runs of CNBr cleaved and CNBr/trypsin cleaved BR were analyzed by 
MS. Representative mass spectra of the many taken are shown in the figures. The 
results of these initial studies are summarized in fig. 6.1 and 6.2. 
Ten peptides ranging in mass from -450 to 5400 are predicted to !esult from CNBr 
cleavage of BR. The predicted fragments are shown in fig. 6.1 and listed in fig. 6.2. 
Tryptic and CNBr digestion leads to many fragments as depicted in fig. 6.1. Those 
peptides that were found are indicated on fig. 6.1 and listed in fig. 6.2. Some sections 
of BR were identified by peptides derived from more than one cleavage. Three of the 
peptides' sequences were confmned by MS/MS including one peptide (BR sequence 
24-32t mass 1023, fig. 6.3, bottom) that was the result of an unusual cleavage between 
glycine and threonine. Some representative MS spectra are shown in fig. 6.4 through 
fig. 6.9. Two of the three confirming MS/MS spectra are shown in fig. 6.3 including 
the spectrum that confirms the sequence of the unusual cleavage fragment. The peptides 
that were found are all below 2600 mass showing a predilection for the HPLC recovery 
or ionization of the smaller peptides. 
Overall 49% of the amino acids in BR were identified by MS. Nine percent of the 
protein was sequenced by MS/MS. Two unusual cleavage sites were identified. One 
was a cleavage between Asp and Pro which is known to be acid labile [Allen, 1981]. 
The other unusual cleavage was between Gly and Thr. The sequence of the peptide 
derived from this latter cleavage was confirmed by tandem mass spectrometry (fig. 6.3, 
bottom). Attempts to identify any mass shifted peptides in the sample from photolysed 
VBN-II (2.) pigment were unsuccessful due to the complexity of the spectra. These 
results of these initial studies indicate the general utility of MS and MS/MS for analysis 
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of BR. 
However, as can be seen in the spectra presented in fig. 6.4, the MS spectra are 
very complex making identification of the peaks difficult. Each of the peaks in these 
spectra were analyzed to determine if they were derived from unusual cleavages or from 
obvious modifications of the protein. Each mass was searched through the sequence of 
BR using MacProMass to determine possible unusual cleavages. Each was also 
searched as the Homoserine and the Homoserine Lactone - the two possible products of 
Met after the CNBr cleavage. It was expected that the peptides containing Thr or Ser 
may be fonnylated during the delipidation and CNBr cleavage steps and shifted in mass 
by a multiple of 28. The unassigned peaks were also checked against spectra derived 
from just the matrix as sample on the probe tip. The difficulty in assigning even some 
of the rather large peaks shows that finding a labeled peptide of possibly low abundance 
would be very difficult Another possible complication is that the label could be 
partially degraded [Bownds, 1967; Dohlman et al., 1988]. This degradation, if 
uniform, would shift the expected mass of the labeled peak. If non-unifonn this 
degradation would spread a possibly already small signal over several peaks making 
them even more difficult to identify. 
The identification of only the smallest peptides indicates an inherent favoring of 
these peptides in one or more steps in the analysis. The larger peptides may be 
inefficiently recovered from the HPLC, may stick to the plastic of the tube, may be 
inefficient! y ionized in the matrices chosen, or inefficiently detected in the mass 
spectrometer. Most of these possible complications were controlled for by routine 
analysis of bovine insulin at mass> 5000. This control showed that the sample 
manipulations and the mass spectrometry worked well for insulin, a water soluble 
hormone, but the large peptides derived from BR are extremely hydrophobic. Thus, 
peptide mapping shows unexpected complexity with many minor, hard to identify peaks 
which decreases the usefulness of peptide mapping as a detection method for moderately 
labeled peptides. 
The simplest way to improve the utility of mass spectral analysis is to use 
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radiolabeled, photoactivatable retinal analogs that would allow identification of the area 
of the chromatogram in which labeled peptides elute. Focusing to one area of the 
chromatogram, if not one peptide, would greatly simplify these analyses. This 
technique has been successfully used on a soluble protein [Chen et al., 1986]. A 
possible control study that could be used to troubleshoot the methods would be 
confmnation ofLys216 as the site of the Schiff base linkage to retinal using RTBR. 
These studies may further the development of the method, but would contribute very 
little new knowledge since the identification of Lys216 as the linkage site is frrmly 
established. 
The results of this mass spectrometric analysis of BR indicate that these methods are 
useful for mapping much of BR, that MS/MS is useful for sequencing peptides from 
BR and that these methods in general would be most useful in analysis of a peptide that 
is known to be labeled. 
- Trypsin Oeavage Sites 
- CNBr Oeavage Sites 
o Determined by MS 
- Unusual Cleavage Site 
#~.~.';: 
~. .~:: Determined by two 
\:;.~;!;,i~ Independent Cleavages 
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Figure 6.1 Summary of Mass Spectrometry Results 
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Graphic summary of MS and MS/MS results on a twp dimensional model of BR (see figure 
1.2). The predicted and unusual sites of cleavage are indicated as well as the peptides found by 







































Unusual Cleavage Fragments 




































Sequence Expected Mass (MH+) Observed Mass (MH+) 
(G)TLYFLVKGHsl 1023.6 1023.3* 
(D)PDAKKFY AIT 
1LVPAIAFfHsI 2150.2 2150.9 
* Sequence Confinned by MS/MS 
Figure 6.2 MS & MS/MS of Peptides from BR 
Hsi = Homoserine lactone 
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Figure 6.3 MS/MS of Two Peptides from Bacteriorhodopsin 
Top panel: MS/MS spectrum of CNBr3 confmning the sequence of this peptide that is a 
predicted product of CNBr cleavage of BR. Bottom panel: MS/MS spectrum of BR 
sequence 24-32 resulting from an unusual cleavage between glycine and threonine. The 
sequence was suspected from a search of the sequence of BR and is confmned by this 
MS/MS spectrum. For symbol identification, refer to Biemann and Martin (1987). 
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Figure 6.4 MS of Bacteriorhodopsin Peptides - A 
MS of CNBrffrypsin cleavage fragments of BR. 
I1/Z 
Top panel: HPLC fraction containing CNBr2 at 1251 rn/z 
and CNBr3 at 2509 m/z. Unidentified peaks are not labeled. 
Bottom panel: CNBr2 in a different HPLC fraction. Note 
complexity of spectrum from a single HPLC peak. 
6-14 
CNBr3 2508.99 (MH+) 
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Figure 6.5 MS of Bacteriorhodopsin Peptides - B 
MS of CNBrffrypsin cleavage fragments of BR. 
Top panel: MS of CNBr3 at 2509 m/z which is the largest 
of the 10 CNBr fragments found. Bottom panel: MS of 
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Figure 6.6 MS of BR Peptides - C 
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Figure 6.7 MS and MS/MS of CNBrS 
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Figure 6.8 MS of Tryptic Fragments of BR 
Top panel: MS of peptide 119-129 at 1029.2 m/z of sequence IGTGLVGALTK; 
Bottom panel: MS of peptide 217-225 at 987.1 m/z of sequence VGFGLILLR. 
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Top panel: MS of CNBr4 at 465.1 m/z; Bottom panel: MS of CNBr5 at 819.1 m/z, 




Summary of Results 
and 
Suggestions for Future Work 
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Eleven different retinal analogs were analyzed as their BR analog pigments. Eight 
of these retinal analogs were photoactivatable and their analysis as BR analog pigments 
detennined which were suitable for further investigation. 
A new flash photolysis apparatus was compared to a continuous wave source. 
These two light sources were compared by chemical actinometry, ability to activate a 
newly synthesized model compound, and likelihood of inducing protein damage. Both 
light sources activated the model compound at total photon counts that induced no 
noticeable damage to BSA or BR. Both sources were used to activate the retinal analog 
based on the model compound. 
Techniques for prediction of photoaffinity labeled sites in BR were developed using 
molecular modeling as a tool. These methods were then used to test the previously 
published accounts of photoaffinity labeling of BR. The results suggest that the retinal 
analog of Huang et ale (1982) was not fully in the retinal binding site ofBR when it 
was activated and labeled the protein. However, the experiments of Ding et al. (1990) 
show labeling of sites very near the photoactivatable group when the analog is placed in 
the native retinal binding pocket. Analysis of the results of Boehm et ale (1990) indicate 
that this retinal analog labeled amino acids that were intermediate between those of 
Huang et al. and Ding et ale for being near the native retinal binding site as mcxleled by 
Henderson et ale (1990). 
It was determined by preliminary studies that radiolabeled retinal analogs would be 
necessary to determine the extent of labeling after photolysis. The two retinal analogs 
that were made in radiolabeled form that formed stable and partially functional BR 
analog pigments (4-oxoretinal S. and TF4N311) were tested for their ability to fonn 
stable crosslinks with the protein upon photolysis. With an estimate of the limit of 
detection of <5%, it was determined that neither of these retinal analogs fonned 
significant amounts of a stable crosslink to the protein on photolysis. In retrospect it 
was realized that the conjugation of the photoactivatable group with the rest of the retinal 
analog likely rendered the photoactivated intermediates from these two retinal analogs 
insufficient! y reactive to label the protein in high yields. 
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In anticipation of labeled protein, mass spectrometric analysis of BR was 
undertaken. This analysis required delipidation, cleavage of the protein by chemical and 
enzymatic means, separation of peptides by HPLC and analysis by MS and MS/MS. 
Forty-nine percent of the protein was identified by MS and 9% was sequenced by 
MS/MS. Two unusual cleavage sites were identified and one of them was confmned by 
MS/MS. These experiments emphasized the need for radioactive tracer to be 
incorporated in the retinal analog to focus the use of mass spectrometry to analysis of a 
certain region of the HPLC chromatogram if not to a particular peptide. 
The major difficulty in these attempts to photoaffmity label BR was the extreme 
difficulty in the synthesis and characterization of photo act iva table retinal analogs. With 
this in mind and the fact that a great deal of effort that is not described in these chapters 
went into isolation and characterization of the retinal analogs in fig. 2.1, it is critical to 
suggest improvements in the design of the retinal analogs that would make them easier 
to synthesize and the photo activated intennediates derived from them more reactive. 
New and improved retinal analogs are required that would be more likely to be useful in 
photoaffinity labeling experiments of BR. 
What is the 'ideal' photoactivatable retinal analog? The photoactivatable group 
must not be in conjugation with the retinal sidechain. The retinal analog should be non-
aromatic. Aromatic rings are sterica1ly very different from cyclohexenyl rings. This is a 
larger change in structure than may be immediately obvious. Aromatic retinal analogs 
that function (pump protons) as the BR analog pigments are unusual [Crouch, 1986]. 
The partial functioning displayed by the TF4N3 pigment was pleasantly surprising. The 
ideal retinal analog should contain a carbene precursor as a photoactivatable group since 
carbenes are more reactive than nitrenes and have been most successful in studies on BR 
and rhodopsin [Huang etaI, 1982; Ding et aI., 1990; Nakayama and Khorana, 1990; 
Boehm et al., 1990]. The retinal analog should be radiolabeled to a high specific 
activity on an atom near the photoactivatable group. The high specific activity would aid 
in identification of even small amounts of labeling. The radiolabel on a proximate atom 
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would decrease the possibility of the degradation of the label leading to separation of the 
radiolabel from the photoactivatable group [Dohlman et al., 1988; Ding et ai., 1990]. 
This ideal retinal analog must be relatively simple to synthesize so as to be available in 
sufficient quantities for complete and timely characterization. The retinal analog 
Nakanishi (ll) is an excellent analog for all of the above reasons (except for possibly 
ease of synthesis and high specific activity, see below). This analog labeled Thr121 and 
Gly122 that are petfectly placed in the retinal binding pocket to be labeled by this 
analog. When synthesized as the optically pure compound, Ding et ale (1990) showed 
that Nakanishi1 J. formed a BR analog pigment that pumped protons as efficiently as the 
regenerated (with ATR) BR. It should be noted that the results of the photoaffinity 
labeling experiments were reported eight years after the initial report [Sen et ai., 1982] 
with an intermediate report on the synthesis of the optically active compound [Ok et al., 
1988]. These reports are from the laboratory of the world's premier retinal chemist. 
Two retinal analogs are being synthesized here that have great potential for being 
excellent photoaffmity labels for BR. One is the acyclicretinal (il, fig.7.1) that 
contains the excellent photoactivatable group, trifluoromethyldiazoproprionate 
[Chowciry et al., 1976], is not aromatic and has already been shown to form a BR 
analog pigment. Several acyclic retinals have been shown to fonn functional BR analog 
pigments [Crouch, 1986]. The BR analog pigment formed with this acyclic retinal 12 
is currently being tested for its functional characteristics. This retinal analog has 
recently been shown to form stable crosslinks to cyclohexane when photolysed in 
solution [John Oatis, personal communication]. One potential drawback of this retinal 
analog is the relatively labile ester linkage between the photoactivatable group and the 
rest of the retinal. For greatest utility this compound should be made radioactive with 
14C in the trifluoromethyldiazoproprionyl moiety. 
The other retinal analog is very similar to this acyclic retinal but is based on valine 
(li, fig. 7.1). This analog has an amide linkage to the photoactivatable group that can 
be methylated to the tertiary amide. The radiolabeling of this compound can be easily 
obtained by purchase of the readily available radiolabeled valine. As a result the 
radiolabel would be attached to the photoactivatable group by a very stable linkage. 
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From the current studies, a flow chart for the most efficient approach to 
photoaffinity labeling experiments of BR can be designed (fig. 7.2). The inherent 
linearity in the design of these studies is one of the greatest difficulties in achieving the 
final goal. Each step must be successfully completed before the next step can be 
reasonably approached. Also, it should be noted that when a decision step fails, one 
must return to the very beginning of the flow chart. This linearity and lack of branching 
points makes the initial steps particularly crucial. The design, synthesis and full 
characterization of a potential photoactivatable retinal analog must be completed before it 
is reasonable to proceed with the next steps. Several times in the present studies 
incompletely chemically characterized retinal analogs were characterized as the BR 
analog pigments only to be redone when the completed chemical characterization 
showed that the retinal analog being analyzed was other than that expected. For 
example, one product of many attempts to synthesize TF4N311 was the 4-
ethoxytetrafluorophenylretinal analog. This compound formed a BR analog pigment 
similar to TF4N3, but was, of course, not photoactivatable. 
Next, the fully characterized retinal analog must be shown to be both a good retinal 
analog by testing as the BR analog pigment AND contain a good photoactivatable group 
by analysis of photolysis in organic solvents. Both of these steps must be completed 
satisfactorily before the preparation of the radiolabeled compound is undertaken. As 
was learned in these experiments, the full retinal analog may act considerably differently 
in the photolysis studies than an easier to synthesize model compound. It is therefore 
suggested that the photolysis in organic solvents experiments be petfonned with the full 
retinal analog. These two steps are presently underway for the acyclic retinaill. 
After the retinal analog has been shown to fonn a good BR analog pigment and been 
shown to contain an excellent photoactivatable group, it should be prepared in 
radiolabeled fonn with the radioactive atom being stably linked to the photoactivatable 
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group. The higher the specific activity, the higher the sensitivity for detecting labeling 
will be. At the very least, 10 mCi/mmol is required. Photolysis can then be petformed 
under conditions shown to be adequate by the studies of the particular retinal analog in 
organic solvents. 
The amount of labeling as detennined by radioactivity associated with BR after 
cleavage of the Schiff base and separation of the retinals from the protein must be 
detennined. A labeling of at least 15% would allow comparison with the previously 
reported photoaffinity labeling of BR that showed labeling from 15-30%. This amount 
of labeling would also facilitate detennination and interpretation of the labeled amino 
acids. 
Once labeled protein has been obtained, a three pronged approach to determining 
sites of labeling using Edman degradation, amino acid analysis and mass spectrometry 
is suggested. The use of an in-line f3-counter would be particularly useful for focusing 
the experiments on a certain area of the chromatogram derived from HPLC analysis of 
the cleaved protein. Amino acid analysis can confIrm which peptide of those derived 
from the cleavage of the protein contains the radiolabel. Edman degradation has the 
drawbacks of being rarely able to identify a single amino acid as the labeled site in a 
peptide [Boehm et al., 1990]. This is especially troublesome when photoaffinity 
labeling is being used in this "higher resolution" context. However, it has been 
successfully used in all of the previous photoaffinity labeling experiments on BR and 
rhodopsin. Mass spectrometry has the potential advantage over Edman degradation 
described in Chapter 1 of identifying a single labeled amino acid site, but is unproven as 
the sole technique for identifying photoaffinity labeled sites. These three techniques 
should prove complementary in identification of labeled sites. 
The overall objective of these experiments - to photoaffinity label BR and to 
determine sites of labeling - has not yet been reached. Several intermediate objectives 
were achieved and these studies suggest possible modifications that will increase the 
7-7 
chances for overall success. The major difficulty in these studies was the difficulty in 
synthesis of the labile photoactivatable retinal analogs. It is hoped that the retinal 
analogs presently being synthesized will, with the foundation laid by this work, provide 
interesting structural information on the retinal binding site of bacteriorhodopsin and 
contribute to the knowledge of drug-receptor interactions by further elucidating the 




Valine Based Retinal 
Figure 7.1 Photoactivatable Retinal Analogs Presently Being Synthesized 
These two retinal analogs possess the excellent photoactivatable group, trifluoromethyl 
diazopropanoate that is NO'r in conjugation with the retinal sidechain. 
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of Retinal Analog 
Photolysis of Retinal Analog 
in Organic Solvents Confirms 
Reactivity of Intermediate 
BOTH ARE YES 
Prepare in Radiolabeled Form 
Photolysis of BR Analog Pigment 
Determine % Labeling 
Site(s) of Labeling 
Determined and Interpreted 
<5% 
Figure 7.2 Suggested Critical Path For Photoaffinity Labeling of BR 
The flow chart represents the suggested most efficient path to 
photo affinity labeling of B R using photoactivatable retinal analogs. 
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Synthesis ofTF4N3 11: 
Step a: Pentafluorobenzaldehyde (Aldrich, 2.4 g, 12.2 mmol) was refluxed with 
sodium azide (Aldrich, 0.8 g, 12.3 mmol) in 26 ml acetone:water 3: 1 for seven hours. 
The product was extracted with ether twice. The extract was dried with magnesium 
sulfate (anhydrous, Sigma). The ether is evaportaed under a stream of nitrogen. 
Yield=100%. UV=2S0 nm. IR=2130 em-I. 
Step b: TF4ABA (2.17 g, 10 romol) was reacted with triethyl-3-methyl-4-
phosphocrotonate (Aldrich, 2.64 g, 10 mmol) in 12 mL sodium bis(trimethylsilyl)amide 
(1.0 M, Aldrich) in tetrahydrofuran. The phosphocrotonate and base were allowed to 
react for O.S h at room temperature. TF4ABA in freshly distilled TIIF was added and 
stirred overnight at room temperature. Water was added to quench the reaction and the 
product was extracted with petroleum ether, dried with magnesium sulfate and 
evaporated under argon. The precipitate was dissolved in the least amount of SO% ethyl 
acetate:hexanes and purified by passage through silica gel and eluting with 10% ethyl 
acetate: hexanes. The pure fractions were crystalline solids. 
Yield=30%. UV=2S0 nm. IR=2137cm-1• MS=303m/z (amine). 
Step c: The ester was dissolved in chloroform and twice the moles of ester of DiBal 
(Aldrich, 1.0 M in chloroform) was added slowly with stirring at 0 C. When the ester 
was fully reacted (absent by TLC), water was added to precipitate aluminum. It was 
filtered, extracted with chloroform, dried with magnesium sulfate, and evaporated with 
argon. The residue was dissolved in SO% ethyl acetate:hexane and purified through a 
silica column eluted with 35% ethyl acetate:hexane. The purified fractions were 
combined and evaporated to dryness. 
Yield=68%. UV=305 nrn. IR= 2127cm- 1. 
Al-3 
Step d: The alcohol was dissolved in chlorofonn. Manganese dioxide which was 
sonicated in deionized water for 24 hours, filtered and dried in an oil bath under house 
vaccuum was added. One gram of manganese dioxide was used per 0.1 g of alcohol. 
The mixture was stirred at room temperature overnight, filtered through celite, dried 
with magnesium sulfate and dried with argon. The solid was dissolved in 50% ethyl 
acetate:hexanes and separated on a silica column with 10% ethyl acetate:hexanes. The 
trans isomer was used for the next step. 
Yield=63%. UV=358 nm. IR=2127cm-1. 
Step e: Same as step b. Yield=82%. UV=378 nm. 
Step f: Same as step c. Yield=65% UV=357 nm. 
Step g: Same as step d. Yield=63%. UV=390 nm. 
Further separation of the isomers was done on a preparative HPLC silica column 
(Econosphere 5Jlm) to obtain the all-trans. The following characterizations were 
performed on the trans isomer: UV-vis, MS, IR, proton NMR, fluorine NMR. 
UV=390nm 
MS=323m/z (nitrene), 325m/z (amine) 
IR=2122cm-1 
fluorine NMR=two peaks in AA-XX- pattern 
proton NMR - showed predominately all-trans isomer 
AI-4 
UV-vis absorbance maximum in ethanol (run) 
compound pentafluofO azido 
benzaldehyde 235 250 
C-5 ester 304 317 
C-5 alcohol 282 305 
C-5 aldehyde 316 358 
C-IO ester 360 383 
C-IO alcohol 345 363 
C-IO aldehyde 370 390 
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Figure Al.2 Mass Spectra of Oxoretinals 5,6, 7 
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Figure Al.3 Protonated Schiff Base Formation for 1 and S. 
UV-vis spectra of formation of protonated Schiff base of retinal (top,l) and 4-oxoretinal 
(bottom, 5). The aldehyde of each has an absorbance maximum at -380 nm, the Schiff 
base with n-butylamine is blue shifted, and the protonated Schiff base is red shifted. 
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Figure Al.4 Protonated Schiff Base Formation of ~ and 7 
UV-vis spectra of fonnation of protonated Schiff base of 2,3-dehydroretinal (top,~ and 
dioxocyc1opentenylretinal (bottom, D. The aldehyde of each has an intennediate 
absorbance maximum, the Schiff base with n-butylamine is blue shifted, and the 
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Figure AI.S Pigment Formation with £ 
UV-vis spectra ofBR analog pigment fonnation with VBN-I 8. The absorbance due to 
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Figure Al.6 Pigment Formation with .2. 
UV-vis spectra ofBR analog pigment formation with VBN-II 9. The absorbance due to 
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Figure AI.7 Characterization of Pigment of VBN-II 2. 
AI-IO 
Top panel: Hydroxylamine Stability: the absorbance of the pigment at -480 nm 
decreases as the peak due to the retinyloxime increases (-360 nm); Bottom panel: ATR 
Stability: the absorbance of the analog pigment (480 nm) is replaced by that of 
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Figure A1.S Characterization of Pigment of TF4N3 11 
Top panel: Irradiation of Pigment at 350 nm for 10 minutes shows irreversible shift 
from 517 nm to 507 nm; Bottom panel: Hydroxylamine Stability of Non-irradiated 
Pigment: the absorbance of the pigment at -520 nm decreases as the peak due to the 
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Figure Al.9 Characterization of Pigment of Acyclicretinal 12 
Al-12 
Top panel: Hydroxylamine Stability: the absorbance of the pigment at -460 nm 
decreases as the peak due to the retinyloxime increases (-340 nm); Bottom panel: ATR 
Stability: the absorbance of the analog pigment (460 nm) is replaced by that of 
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Figure At.tO Characterization of Pentafluororetinal U 
Top panel: Formation ofPSB:Aldehyde (360 nrn), Schiff base: -360 nrn (fine structure 
and PSB: (407 run); Bottom panel: Pigment Formation: Increase in absorbance of BR 
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Figure AI.II Characterization of Pigment of Pentafluororetinal U 
Bottom panel: Hydroxylamine Stability: the absorbance of the pigment at -460 nm 
decreases as the peak due to the retinyloxime increases (-340 nm); Top panel: ATR 
Stability: the absorbance of the analog pigment (460 nm) is replaced by that of 
regenerated BR (570 nm) when the analog pigment is incubated with excess ATR (380 
nm). 
Figure Al.12 Characterization of Hydroxyretinal 14 
Top panel: Formation of PSB:Aldehyde (386 nm), Schiff base: 350 nm and PSB: (456 
nm); Bottom panel: Pigment Formation: Increase in absorbance of BR analog pigment 
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Figure AI.13 Characterization of Pigment of Methoxyretinal II 
Al-16 
Top panel: Pigment Formation: increas in absorbance due to BR analog pgment 
formation (490 nm) with time of incubation; Bottom panel: Hydroxylamine 
Stability:decrease in absorbance of pigment (490 nm) with increase in absorbance of 
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Figure Al.14 Characterization of Pigment of II (cont.) 
AI-I7 
ATR Stability: Replacement of absorbance of BR analog pigment with regenerated BR 
(570 nm) on incubation with ATR (380 nrn). 
Appendix 2 
Sequence Analysis of Shark Immunoglobulin Light Chains 
using Tandem Mass Spectrometry 
Portions of this appendix have been published as 
Schluter, SF, CJ Beischel, SA Martin, and JJ Marchalonis. 
"Sequence Analysis of Homogeneous Peptides of Shark Immunoglobulin Light Chains 
by Tandem Mass Spectrometry: Correlation with Gene Sequence and Homologies 
among Variable and Constant Region Peptides of Sharks and Mammals." 
Molecular Immunology 27(1), 17-23, 1990. 
A2-1 
Introduction. This appendix presents the application of mass spectrometry (MS) to 
define protein structure for immunoglobulin light chains from two different species of 
shark. This analysis was undertaken as a training experience in mass spectrometric 
analysis of proteins and peptides at the Massachusetts Institute of Technology before a 
mass spectrometer with the required capabilities was installed at the Medical University 
of South Carolina. The analysis was performed in collaboration with Jack Marchalonis, 
Sam Schluter and Steve Martin. The derivation of sequence information from 
polyclonal shark light chains is particualarly suited to analysis by MS since this method 
is tolerant of the peptide mixtures that inherently result from the large variability in these 
polyclonal proteins. 
The goal of this analysis beyond training was to obtain further information on the 
sequence of shark immunoglobulin light chains to be used in phylogenetic studies and in 
the preparartion of oligonucleotide probes for the screening of genomic libraries. 
Peptides isolated from tryptic digests of purified tiger shark and sandbar shark 
polyclonallight chains [Rosenshein and Marchalonis, 1987] were sequenced. The 
peptides were fractionated by reversed-phase HPLC and sequenced using high-
resolution tandem mass spectrometry [Biemann, 1992]. It was feasible to apply this 
combination of technologies to polyclonallight chain pools to obtain unique amino acid 
sequences corresponding to variable and constant region segments of shark light chain. 
A2-2 
Methods. The carboxamidomethylated immunoglobulins [Rosen shein and 
Marchalonis, 1987] (25 nmol) were dissolved in 0.1 M ammonium carbonate, 0.1 M 
calcium chloride at 5 mg/mL, and digested with trypsin (1 % by weight) for 1 hour at pH 
8.5 and 37 C. The tryptic digest was separated by reversed-phase HPLC and prepared 
for mass spectrometric analysis [Martin et ai., 1982]. 
The HPLC separartion was done on a CI8 column using a linear gradient from 
100% water (containing 0.05% TFA) to 70% acetonitrile (containing 0.035% TFA) in 
70 min at a flow rate of 1.0 ml/min. Individual peaks were collected manually. A small 
amount of glycerol (2-5 JlI) was added to each sample tube and the HPLC solvents 
removed by evaporation using a Speed-Vac Concentrator. One microliter of 10% 
aqueous acetic acid was mixed with each sample (1-2 nmol) and they were analyzed by 
FAB MS and MS/MS [Johnson and Biemann, 1987]. 
A2-3 
Results and Discussion. The shark immunoglobulin light chains were digested with 
trypsin following the procedure of Allen (1981) and separated by HPLC under 
reversed-phase conditions. All fractions that were isolated in discrete fonn from both 
the tiger shark and sandbar shark light chain digests were characterized in terms of 
molecular weights, and some fragments were further analyzed for assignmemt of 
primary amino acid sequence by MS/MS. Ten peptides ranging from a pentamer to a 
16-mer were completely sequenced and are shown in fig. A2.1. One tryptic fragment 
(moL wt. 1582.1) was found in both the tiger shark digest (Tf13) and the sandbar shark 
digest (Sf12). The sequences of these peptides were subsequently derived from DNA 
sequencing. The fact that had originally been sequenced at the protein level confmns the 
identification of the stretch of DNA that was sequenced as a major expressed 
immunoglobulin gene. 
The use of MS/MS to establish primary sequence of peptides is illustarted in fig. 
A2.2, which compares analyses of tiger shark Tf10 and sandbar shark Sf9 peptides. 
The primary sequence of these two peptides (tiger shark Tf10, 795.5 and sandbar shark 
Sf9, 781.5) differ by a single amino acid substitution in position 4 (TIe to Val; Johnson 
et al., 1987). A comparison of their tandem mass spectra indicates the substitution and 
the subsequent 14 unit mass shift in all ions containing the change. This shift in mass is 
very similar to that outlined in fig. 1.10 that describes MS/MS of chemically modified 
peptides. In this case the chemical modification is addition of a methyl group at position 
4 by changing a valine to a isoleucine. The use of these peptide sequences to con finn 
DNA sequencing from shark cDNA libraries and their use in phylogenetic studies are 




























bFAB MS/MS spectrum fig. 6.6b. 











D-P-V -L-T -Q-P -G-S -1-S -S -S -P -G -K 
A2-4 
dBath of these components were in the same HPLC fraction. Full sequence 
infonnation was obtained from both peptides in the fraction with no interference. 
CpAB MS/MS spectrum fig. 6.6a. 
fX indicates elther I or L. 
Figure A2.1 Sequence of Peptides from Shark Ig Light Chains Derived 
by FAB MS/MS. 
Observed molecular weights and deduced primary sequences for tryptic peptides from 
the light chains of tiger and sandbar shark Ig obtained from FAB MS and FAB MS/MS. 
A2-5 
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Figure A2.2 MS/MS Spectra of Tryptic Peptides From Shark 
Immunoglobulin Light Chains 
(a) Sandbar shark (M+H)+ 781.5 and (b) Tiger shark (M+H)+ 795.5, highlighting 
the identificationof a single amino acid substitution. All C-terminal fragment 
ions (i.e. wn+ 1, xn ' Yn, and zn) from n=4,5, etc. are observed at a mass 14 
higher in (b) , indicating a modification in position 4 . This is further supported 
by the abundant immonium ion (m/z 72.0) and R group loss [(M+H)+-43=738.1] 
for Val in (a) and the replacement of these ions by an immonium ion (m/z 86.0) 
and R group loss [(M+H)+-57=738.1] for xLeu in (b) . The xLeu was identified 
as Ile, based on the characteristic w 4a and w 4b ions at m/z 445 and 459 
respectively in (b). Adapted from Schluter et al., 1990. 
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